<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm: Ativan</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 7000 RSS medical sources are combined and output via different filters. This feed contains the latest news and research in the Ativan category.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Ativan+lorazepam&kid=33599&t=Ativan&f=drugs]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 06:38:36 +0100</lastBuildDate>
        <item>
            <title>Lorazepam/alcohol interaction: Fall leading to subdural haematoma in an elderly patient: case report</title>
            <link>http://www.medworm.com/index.php?rid=5660016&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2012%2F00000001%2F00001387%2Fart00085</link>
            <description>(Source: Reactions)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5660016</comments>
            <pubDate>Sun, 05 Feb 2012 18:29:54 +0100</pubDate>
            <guid isPermaLink="false">5660016</guid>        </item>
        <item>
            <title>All bath salts are not mephedrone</title>
            <link>http://www.medworm.com/index.php?rid=5663524&amp;cid=c_33599_57_f&amp;fid=39029&amp;url=http%3A%2F%2Fwww.thepoisonreview.com%2F2012%2F02%2F04%2Fall-bath-salts-are-not-mephedrone%2F</link>
            <description>2.5 out of 5 stars
&amp;#8220;Bath Salt&amp;#8221; Ingestion Leading to Severe Intoxication Delirium: Two Cases and a Brief Review of the Emergence of Mephedrone Use. Kasick DP et al. Am J Drug Alcohol Abuse 2012 Jan 5 [Epub ahead of print]
Abstract 
This paper from the Ohio State Department of Psychiatry is worth reading for vivid descriptions of acute toxic delirium in two patients after they used a product sold as &amp;#8220;bath salts&amp;#8221;:

Patient A presented after ingesting &amp;#8220;bath salts&amp;#8221; sold under the label &amp;#8220;Arctic Blast&amp;#8221;. He was tachycardic (heart rate = 144.min), anxious and paranoid, and suffering visual hallucinations of snakes. For some bizarre reason he was given 2 mg naloxone in the field. At the hospital, he slowly improved after treatment with fluids, lorazep...</description>
            <author>The Poison Review</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663524</comments>
            <pubDate>Sat, 04 Feb 2012 05:56:41 +0100</pubDate>
            <guid isPermaLink="false">5663524</guid>        </item>
        <item>
            <title>Hurry Up! Let's Talk About Anxiety!</title>
            <link>http://www.medworm.com/index.php?rid=5651838&amp;cid=c_33599_36_f&amp;fid=35653&amp;url=http%3A%2F%2Fwww.psychologytoday.com%2Fblog%2Fthe-90-minute-checkup%2F201202%2Fhurry-lets-talk-about-anxiety</link>
            <description>It's a catch phrase, &quot;I'm nervous&quot;.&amp;nbsp; My seven year-old is anxious his basketball team might lose against the orange team this weekend.&amp;nbsp; Anxiety and the anxious lexicon have crept into our society over the past decades and we as a culture have turned into a bundle of nervous.&amp;nbsp; So many people are placed on anxiolytics like Xanax or Ativan; which is like getting a brand new car.&amp;nbsread more (Source: Psychology Today Anxiety Center)</description>
            <author>Psychology Today Anxiety Center</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651838</comments>
            <pubDate>Fri, 03 Feb 2012 06:32:23 +0100</pubDate>
            <guid isPermaLink="false">5651838</guid>        </item>
        <item>
            <title>Fentanyl/lorazepam/morphine: Recurrent delirium in an infant: case report</title>
            <link>http://www.medworm.com/index.php?rid=5648207&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2012%2F00000001%2F00001386%2Fart00073</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5648207</comments>
            <pubDate>Thu, 02 Feb 2012 18:34:27 +0100</pubDate>
            <guid isPermaLink="false">5648207</guid>        </item>
        <item>
            <title>Muscle relaxants for pain management in rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5648691&amp;cid=c_33599_13_f&amp;fid=38891&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FEvidence%2FDrug-Class-Focused-Reviews%2FMuscle-relaxants-for-pain-management-in-rheumatoid-arthritis%2F</link>
            <description>Source: Cochrane Library
Area: Evidence &amp;#62; Drug Class Focused Reviews
 Background 
 Pain management is a high priority for patients with rheumatoid arthritis (RA). Muscle relaxants include drugs that reduce muscle spasm (for example benzodiazepines such as diazepam (Valium), alprazolam (Xanax), lorazepam (Ativan) and non-benzodiazepines such as metaxalone (Skelaxin) or a combination of paracetamol and orphenadrine (Muscol)) and drugs that prevent increased muscle tone (baclofen and dantrolene). Despite a paucity of evidence supporting their use, antispasmodic and antispasticity muscle relaxants have gained widespread clinical acceptance as adjuvants in the management of patients with chronic musculoskeletal pain. 
   &amp;#160; 
   &amp;#160; 
  Objectives The aim of this review was to determin...</description>
            <author>NeLM - Drug Class Focused Reviews</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5648691</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5648691</guid>        </item>
        <item>
            <title>Muscle relaxants for pain management in rheumatoid arthritis.</title>
            <link>http://www.medworm.com/index.php?rid=5627652&amp;cid=c_33599_22_f&amp;fid=38107&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22258993%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Based upon the currently available evidence in patients with RA, benzodiazepines (diazepam and triazolam) do not appear to be beneficial in improving pain over 24 hours or one week. The non-benzodiazepine agent zopiclone also did not significantly reduce pain over two weeks. However, even short term muscle relaxant use (24 hours to 2 weeks) is associated with significant adverse events, predominantly drowsiness and dizziness.
    PMID: 22258993 [PubMed - in process] (Source: Cochrane Database of Systematic Reviews)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Cochrane Database of Systematic Reviews</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5627652</comments>
            <pubDate>Thu, 26 Jan 2012 08:18:08 +0100</pubDate>
            <guid isPermaLink="false">5627652</guid>        </item>
        <item>
            <title>“ABH Gel” (Ativan®, Lorazepam; Benadryl®, Diphenhydramine; Haloperidol, Haldol®) Is Not Absorbed From the Skin of Normal Volunteers So Cannot Be Effective Against Nausea (411-C)</title>
            <link>http://www.medworm.com/index.php?rid=5604703&amp;cid=c_33599_78_f&amp;fid=38521&amp;url=http%3A%2F%2Fwww.jpsmjournal.com%2Farticle%2FPIIS0885392411006750%2Fabstract%3Frss%3Dyes</link>
            <description>Recognize that the commonly used “ABH gel” (Ativan®, lorazepam; Benadryl®, diphenhydramine; haloperidol, Haldol®) is not absorbed to therapeutic levels from skin, so it cannot be effective as an anti-nausea drug. (Source: Journal of Pain and Symptom Management)</description>
            <author>Journal of Pain and Symptom Management</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5604703</comments>
            <pubDate>Thu, 19 Jan 2012 03:24:50 +0100</pubDate>
            <guid isPermaLink="false">5604703</guid>        </item>
        <item>
            <title>[Status epilepticus.]</title>
            <link>http://www.medworm.com/index.php?rid=5607466&amp;cid=c_33599_25_f&amp;fid=36790&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22249602%26dopt%3DAbstract</link>
            <description>Authors: Feddersen B, Trinka E
    Abstract
    Status epilepticus (SE) is a medical emergency. For diagnostic purposes EEG is mandatory when motor phenomena are absent or when a single seizure evolves into SE with impaired consciousness. The EEG may show focal or generalized status patterns, which must be distinguished from encephalopathies. Initially benzodiazepines are recommended; lorazepam is the drug of choice. When the SE persists, phenytoin, valproate, levetiracetam, lacosamide, and phenobarbital are administered. The choice depends on the underlying comorbidities. In this phase, only phenytoin is licensed. A generalized tonic-clonic status which is refractory is then treated with anesthetics including midazolam, disoprivan, or thiopental. The goal is to achieve burst suppression i...</description>
            <author>Der Nervenarzt</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5607466</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5607466</guid>        </item>
        <item>
            <title>Implications of Objective vs Subjective Delirium Assessment in Surgical Intensive Care Patients.</title>
            <link>http://www.medworm.com/index.php?rid=5570224&amp;cid=c_33599_27_f&amp;fid=37384&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22210705%26dopt%3DAbstract</link>
            <description>Conclusions Use of objective criteria helped detect delirium in more patients and also identified patients mistakenly thought to have delirium who actually did not meet objective criteria for diagnosis of the condition.
    PMID: 22210705 [PubMed - as supplied by publisher] (Source: American Journal of Critical Care)</description>
            <author>American Journal of Critical Care</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5570224</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5570224</guid>        </item>
        <item>
            <title>Response rate of catatonia to electroconvulsive therapy and its clinical correlates</title>
            <link>http://www.medworm.com/index.php?rid=5557382&amp;cid=c_33599_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F95346344764103p0%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Electroconvulsive therapy (ECT) is an important treatment for catatonia. We aimed to study the response rate of catatonia
 treated with ECT and its clinical correlates in a large sample of inpatients. The ECT parameters of all patients (n&amp;nbsp;=&amp;nbsp;63) admitted with catatonia between the months of January and December 2007 were examined. The number of ECTs administered,
 seizure threshold, failure to achieve adequate seizures and clinical signs pertaining to catatonia were analyzed. Response
 was considered as complete resolution of catatonic symptoms with Bush Francis Catatonia Rating Scale (BFCRS) score becoming
 zero. ECT was mostly started after failed lorazepam treatment except in 6 patients where ECT was the first choice. Patients
 who responded in 4 ECT session...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5557382</comments>
            <pubDate>Fri, 30 Dec 2011 07:08:56 +0100</pubDate>
            <guid isPermaLink="false">5557382</guid>        </item>
        <item>
            <title>Time to Worry About Worrying Too Much</title>
            <link>http://www.medworm.com/index.php?rid=5546377&amp;cid=c_33599_36_f&amp;fid=35653&amp;url=http%3A%2F%2Fwww.psychologytoday.com%2Fblog%2Fhow-risky-is-it-really%2F201112%2Ftime-worry-about-worrying-too-much</link>
            <description>Worrying can be really bad for our health, worse by far than some of the things we worry about. It causes the biological harms of chronic stress, which are broad and profound. 
   Primary Topic:&amp;nbsp;
  
      
          Anxiety    
    

read more (Source: Psychology Today Anxiety Center)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Psychology Today Anxiety Center</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5546377</comments>
            <pubDate>Tue, 27 Dec 2011 16:26:41 +0100</pubDate>
            <guid isPermaLink="false">5546377</guid>        </item>
        <item>
            <title>A case of lorazepam (Ativan)-induced accommodation paresis</title>
            <link>http://www.medworm.com/index.php?rid=5539611&amp;cid=c_33599_30_f&amp;fid=32303&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Feye%2Frss%2Faop%2F%7E3%2F4iJbnLq-DUs%2Feye.2011.346</link>
            <description>Authors: J J Jung, S-H Baek
          &amp; U S Kim (Source: Eye)</description>
            <author>Eye</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539611</comments>
            <pubDate>Fri, 23 Dec 2011 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">5539611</guid>        </item>
        <item>
            <title>Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages</title>
            <link>http://www.medworm.com/index.php?rid=5544713&amp;cid=c_33599_13_f&amp;fid=33420&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg7754668871h57gk%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Efforts to reduce the use of BZD/Zs in nursing homes should concentrate on insomnia, with interventions aimed at reducing
 too high prevalence of chronic use and too high daily dosages in this indication.
 
 
 
 
	Content Type Journal ArticleCategory Pharmacoepidemiology and PrescriptionPages 1-12DOI 10.1007/s00228-011-1188-zAuthors
		Jolyce Bourgeois, Heymans Institute of Pharmacology, Ghent University, De Pintelaan 185 (1 blok B), 9000 Ghent, BelgiumMonique M. Elseviers, Heymans Institute of Pharmacology, Ghent University, De Pintelaan 185 (1 blok B), 9000 Ghent, BelgiumMajda Azermai, Heymans Institute of Pharmacology, Ghent University, De Pintelaan 185 (1 blok B), 9000 Ghent, BelgiumLuc Van Bortel, Heymans Institute of Pharmacology, Ghent University, De Pintelaan 1...</description>
            <author>European Journal of Clinical Pharmacology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544713</comments>
            <pubDate>Wed, 21 Dec 2011 20:06:35 +0100</pubDate>
            <guid isPermaLink="false">5544713</guid>        </item>
        <item>
            <title>Diazepam/lorazepam: Respiratory depression in children: 5 case reports</title>
            <link>http://www.medworm.com/index.php?rid=5505131&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001381%2Fart00036</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5505131</comments>
            <pubDate>Fri, 16 Dec 2011 06:55:18 +0100</pubDate>
            <guid isPermaLink="false">5505131</guid>        </item>
        <item>
            <title>Persistent hypothermia after intrathecal morphine: case report and literature review.</title>
            <link>http://www.medworm.com/index.php?rid=5514529&amp;cid=c_33599_5_f&amp;fid=37738&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22161244%26dopt%3DAbstract</link>
            <description>CONCLUSION:            Patients undergoing spinal anesthesia with intrathecal morphine may develop postoperative hypothermia that is resistant to warming measures. This complication may be treated successfully with lorazepam.
    PMID: 22161244 [PubMed - as supplied by publisher] (Source: Canadian Journal of Anaesthesia)</description>
            <author>Canadian Journal of Anaesthesia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5514529</comments>
            <pubDate>Sat, 10 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5514529</guid>        </item>
        <item>
            <title>Table of Contents</title>
            <link>http://www.medworm.com/index.php?rid=5484892&amp;cid=c_33599_172_f&amp;fid=33592&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fpu.20155</link>
            <description>AbstractIncreasing Off‐Label Use of Antipsychotics for Treating Anxiety DisordersLow‐Dose Antipsychotics Generally Safe in Patients with Intellectual Disability, but Caution Still AdvisedWarfarin and AntidepressantsClinical Guidance for Long‐Term T3 Augmentation in Major DepressionGreater Fracture Risk with Zolpidem Than Alprazolam or Lorazepam in the ElderlySlowing AD Progression with MemantineEPA Supplements for DepressionRisperidone and Decompensation in a Previously Stable PatientNew ApprovalsVarenicline Safety ReviewAdverse Linezolid Interactions with Certain Serotonergic Drugs (Source: The Brown University Psychopharmacology Update)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>The Brown University Psychopharmacology Update</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5484892</comments>
            <pubDate>Fri, 09 Dec 2011 03:36:17 +0100</pubDate>
            <guid isPermaLink="false">5484892</guid>        </item>
        <item>
            <title>Lorazepam overdose: Unresponsiveness in an elderly patient, treated with flumazenil: case report</title>
            <link>http://www.medworm.com/index.php?rid=5458055&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001379%2Fart00094</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5458055</comments>
            <pubDate>Thu, 01 Dec 2011 07:29:01 +0100</pubDate>
            <guid isPermaLink="false">5458055</guid>        </item>
        <item>
            <title>Management of Acute Seizure and Status Epilepticus in Pediatric Emergency</title>
            <link>http://www.medworm.com/index.php?rid=5451016&amp;cid=c_33599_33_f&amp;fid=35971&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F634554818v256m99%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Acute seizure and status epilepticus constitute one of the major medical emergencies in children. Among children, the incidence
 ranges from 4-38/100,000 children per year respectively. The incidence in developing countries is somewhat higher because
 of infections. Although, the definition of status epilepticus is based on duration of seizures, the operational definition
 is to treat any child who is brought seizing to the emergency room, as status epilepticus. An urgent time bound approach is
 of paramount importance when managing a child in status epilepticus. Benzodiazepines remain the first line antiepileptic drugs
 in the emergency room; a long acting drug (Lorazepam) is preferred when available. This is followed by Phenytoin (20&amp;nbsp;mg/kg)
 loading. In patients ...</description>
            <author>Indian Journal of Pediatrics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5451016</comments>
            <pubDate>Fri, 25 Nov 2011 17:58:21 +0100</pubDate>
            <guid isPermaLink="false">5451016</guid>        </item>
        <item>
            <title>Density spectral array analysis of SREDA during EEG-video monitoring.</title>
            <link>http://www.medworm.com/index.php?rid=5519712&amp;cid=c_33599_25_f&amp;fid=35404&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22100860%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The temporal pattern of SREDA varies during the sleep-wake cycle. Lorazepam appears to suppress SREDA. SIGNIFICANCE: Response to lorazepam cannot distinguish SREDA from electrographic seizure activity.
    PMID: 22100860 [PubMed - as supplied by publisher] (Source: Clinical Neurophysiology)</description>
            <author>Clinical Neurophysiology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5519712</comments>
            <pubDate>Thu, 17 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5519712</guid>        </item>
        <item>
            <title>Altering Intensive Care Sedation Paradigms to Improve Patient Outcomes</title>
            <link>http://www.medworm.com/index.php?rid=5399983&amp;cid=c_33599_5_f&amp;fid=37500&amp;url=http%3A%2F%2Fwww.anesthesiology.theclinics.com%2Farticle%2FPIIS1932227511000814%2Fabstract%3Frss%3Dyes</link>
            <description>Providing sedation and comfort for intensive care patients has evolved in the last few years. New approaches to improving outcomes for intensive care unit (ICU) patients include providing analgesia before adding sedation and recognizing dangerous adverse effects associated with sedative medications, such as prolonged effects of midazolam, propylene glycol toxicity with lorazepam, propofol infusion syndrome, the deliriogenic effects of benzodiazepines and propofol, and bradycardia with dexmedetomidine. There are now reliable and valid ways to monitor pain and delirium in ICU patients. Dexmedetomidine reduces the incidence of delirium, reduces the duration of mechanical ventilation, and appears to be cost effective. (Source: Anesthesiology Clinics)</description>
            <author>Anesthesiology Clinics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5399983</comments>
            <pubDate>Sun, 13 Nov 2011 00:51:36 +0100</pubDate>
            <guid isPermaLink="false">5399983</guid>        </item>
        <item>
            <title>First prescription of new elderly patients attending the psychiatry outpatient of a tertiary care institute in North India</title>
            <link>http://www.medworm.com/index.php?rid=5388594&amp;cid=c_33599_18_f&amp;fid=28410&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1447-0594.2011.00767.x</link>
            <description>Conclusions:  Olanzapine, SSRI and clonazepam were the most commonly prescribed antipsychotic, antidepressant, and benzodiazepine, respectively, and valproate was preferred over lithium among elderly patients with bipolar disorder. Geriatr Gerontol Int 2011; ••: ••–••. (Source: Geriatrics and Gerontology International)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Geriatrics and Gerontology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5388594</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5388594</guid>        </item>
        <item>
            <title>Interactions Among Benzodiazepine and Buprenorphine/Naloxone</title>
            <link>http://www.medworm.com/index.php?rid=5562273&amp;cid=c_33599_27_f&amp;fid=37688&amp;url=http%3A%2F%2Fwww.jenonline.org%2Farticle%2FPIIS0099176711004260%2Fabstract%3Frss%3Dyes</link>
            <description>We read with interest the recent article by Heather Martin entitled “The Possible Consequences of Combining Lorazepam and Buprenorphine/Naloxone: A Case Review.” It is an interesting case study and we would like to express our thoughts on the drug interactions among benzodiazepine and buprenorphine/naloxone based on the literature review. (Source: Journal of Emergency Nursing: JEN)</description>
            <author>Journal of Emergency Nursing: JEN</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5562273</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5562273</guid>        </item>
        <item>
            <title>[Suitability of the use of benzodiazepines prescribed by the pharmacist in the elderly. A doctor-pharmacist collaboration study.]</title>
            <link>http://www.medworm.com/index.php?rid=5353354&amp;cid=c_33599_35_f&amp;fid=37560&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22023889%26dopt%3DAbstract</link>
            <description>CONCLUSION: The use of benzodiazepines in the Community of Valencia exceeds the recommendations of the Spanish Medicines Agency.
    PMID: 22023889 [PubMed - as supplied by publisher] (Source: Atencion Primaria)</description>
            <author>Atencion Primaria</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5353354</comments>
            <pubDate>Sat, 22 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5353354</guid>        </item>
        <item>
            <title>Jackson got more sedative than doc admits: expert</title>
            <link>http://www.medworm.com/index.php?rid=5332254&amp;cid=c_33599_26_f&amp;fid=23271&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Freuters%2FhealthNews%2F%7E3%2FK8AMmw-mPlE%2Fus-jackson-sedative-idUSTRE79J7VM20111020</link>
            <description>LOS ANGELES (Reuters) - Michael Jackson had more of the sedative lorazepam in his blood stream than his doctor admitted giving him on the day he died, a top anesthesiology expert testified on Thursday. (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5332254</comments>
            <pubDate>Thu, 20 Oct 2011 20:14:09 +0100</pubDate>
            <guid isPermaLink="false">5332254</guid>        </item>
        <item>
            <title>Zolpidem associated with higher risk of fractures compared to lorazepam and alprazolam, and similar risk to diazepam</title>
            <link>http://www.medworm.com/index.php?rid=5332956&amp;cid=c_33599_172_f&amp;fid=27210&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FNews%2F2011---October%2F19%2FZolpidem-associated-with-higher-risk-of-fractures-compared-to-lorazepam-and-alprazolam-and-similar-risk-to-diazepam%2F</link>
            <description>Source: Journal of the American Geriatrics Society
Area: News
 The Journal of the American Geriatric Society has featured a retrospective cohort study to determine whether zolpidem is a safer alternative to benzodiazepines. 
 The community based study involved patients with an initial prescription for zolpidem (n = 43,343), alprazolam (n = 103,790), lorazepam (n = 150,858), or diazepam (n = 93,618), and rates of non-vertebral fractures and hip fractures requiring hospitalisation were compared before and after an initial prescription for each treatment, adjusting for confounders. 
 The following results were reported: .&amp;nbsp;In patients aged 65 and older, the rates of non-vertebral fractures and dislocations were similar in the pre- treatment intervals. .&amp;nbsp;The rate ratios (RRs) for the ...</description>
            <author>NeLM - Mental Health</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5332956</comments>
            <pubDate>Wed, 19 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5332956</guid>        </item>
        <item>
            <title>Avoiding crystallization of lorazepam during infusion.</title>
            <link>http://www.medworm.com/index.php?rid=5363463&amp;cid=c_33599_13_f&amp;fid=35549&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22024382%26dopt%3DAbstract</link>
            <description>Authors: Vellema J, Hunfeld NG, Van den Akker HE, Ter Horst JH
    Abstract
    Lorazepam is a strong sedative for intensive care patients and a commonly used method of administering it to the patient is by infusion of a freshly prepared lorazepam solution. During lorazepam infusion often unwanted lorazepam crystallization occurs, resulting in line obstruction and reduced lorazepam concentrations. With the aid of solubility measurements a solid-liquid phase diagram for lorazepam in mixtures of a commercially available lorazepam solution and an aqueous glucose solution was determined. This confirmed that the glucose solution acts as an anti-solvent, greatly reducing the lorazepam solubility in the infusion solution. Three approaches are proposed to obtain stable lorazepam solutions upon mix...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>European Journal of Pharmaceutical Sciences</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5363463</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5363463</guid>        </item>
        <item>
            <title>Stimulus-Induced Rhythmic, Periodic, or Ictal Discharges in a 13-Year-Old Girl After an Overdose and Respiratory Arrest</title>
            <link>http://www.medworm.com/index.php?rid=5316934&amp;cid=c_33599_25_f&amp;fid=36866&amp;url=http%3A%2F%2Fwww.pedneur.com%2Farticle%2FPIIS0887899411003584%2Fabstract%3Frss%3Dyes</link>
            <description>Paramedics found a 13-year-old, previously healthy girl with depression at home and unresponsive after overdosing on bupropion and baclofen. She was observed to be in respiratory arrest and bradycardic, with a Glasgow Coma Scale score of 3. Chest compressions were required, and she was intubated. During transport, she was hypothermic with decerebrate posturing, and manifested a 1-minute, self-terminating, generalized tonic-clonic seizure. In the pediatric intensive care unit, she received intermittent doses of lorazepam and fentanyl for sedation. She remained comatose, and continuous video-electroencephalogram monitoring was initiated to evaluate her for nonconvulsive seizures. (Source: Pediatric Neurology)</description>
            <author>Pediatric Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316934</comments>
            <pubDate>Sat, 15 Oct 2011 15:43:04 +0100</pubDate>
            <guid isPermaLink="false">5316934</guid>        </item>
        <item>
            <title>[Rapid tranquillisation; review of the literature and recommendations].</title>
            <link>http://www.medworm.com/index.php?rid=5313380&amp;cid=c_33599_172_f&amp;fid=36110&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21989751%26dopt%3DAbstract</link>
            <description>Authors: Bak M, van Os J, Marcelis M
    Abstract
    &amp;lt;p class=&quot;CM4&quot;&amp;gt;&amp;lt;span class=&quot;subtitle&quot;&amp;gt;summary&amp;lt;/span&amp;gt; &amp;lt;span class=&quot;subtitle&quot;&amp;gt;background &amp;lt;/span&amp;gt;In The Netherlands, no guidelines exist for rapid tranquillisation in the contextof acute agitation, excitementor aggression secondarytoapsychiatric disorder. &amp;lt;span class=&quot;subtitle&quot;&amp;gt;aim &amp;lt;/span&amp;gt;To generate an overview of medication regimes suitable for rapid tranquillisation. &amp;lt;span class=&quot;subtitle&quot;&amp;gt;method&amp;lt;/span&amp;gt; Aliterature search was conducted focussing on the effect of medical interventions in acute excitement, agitation or aggression. Primary outcome measurements were tranquillity, being calm, sedation, or asleep within two hours. Secondary outcome measures were frequency of re-administrat...</description>
            <author>Tijdschrift voor Psychiatrie</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5313380</comments>
            <pubDate>Fri, 14 Oct 2011 17:25:04 +0100</pubDate>
            <guid isPermaLink="false">5313380</guid>        </item>
        <item>
            <title>Preliminary evidence of anxiolytic effects of the CRF1 receptor antagonist R317573 in the 7.5% CO2 proof-of-concept experimental model of human anxiety</title>
            <link>http://www.medworm.com/index.php?rid=5312325&amp;cid=c_33599_172_f&amp;fid=27156&amp;url=http%3A%2F%2Fjop.sagepub.com%2Fcgi%2Fcontent%2Fabstract%2F25%2F9%2F1199%3Frss%3D1</link>
            <description>We have validated the use of prolonged inhalation of 7.5% carbon dioxide (CO2) as a human model of anxiety and have shown that drugs from two prototypical classes of anxiolytics, benzodiazepines and a serotonin reuptake inhibitor, attenuate CO2-induced symptoms (Bailey et al., 2007a). Preclinical evidence suggests that drugs acting at the corticotropin-releasing factor (CRF) system may be useful for the treatment of depression, anxiety, and other stress-related disorders (Valdez, 2006), hence we have now examined the effects of a CRF1 receptor antagonist in the 7.5% CO2 model. In a randomized double-blind, placebo-controlled, study in 32 healthy participants we examined the effects of 7 days of treatment with the CRF1 receptor antagonist, R317573, at a dose that shows a favourable safety p...</description>
            <author>Journal of Psychopharmacology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5312325</comments>
            <pubDate>Wed, 12 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5312325</guid>        </item>
        <item>
            <title>Status Epilepticus-Induced Hyperemia and Brain Tissue Hypoxia After Cardiac Arrest [Observation]</title>
            <link>http://www.medworm.com/index.php?rid=5305807&amp;cid=c_33599_25_f&amp;fid=32198&amp;url=http%3A%2F%2Farchneur.ama-assn.org%2Fcgi%2Fcontent%2Fshort%2F68%2F10%2F1323%3Frss%3D1</link>
            <description>Conclusion&amp;nbsp; Brain multimodality monitoring is a feasible method for evaluating secondary brain injury associated with seizure activity after cardiac arrest. (Source: Archives of Neurology)</description>
            <author>Archives of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5305807</comments>
            <pubDate>Mon, 10 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5305807</guid>        </item>
        <item>
            <title>Neuroleptic Malignant Syndrome Associated with the Use of Prochlorperazine in a Patient with a Recent   History of Antipsychotic-Induced Neuroleptic Malignant Syndrome (November).</title>
            <link>http://www.medworm.com/index.php?rid=5301749&amp;cid=c_33599_13_f&amp;fid=37308&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21972252%26dopt%3DAbstract</link>
            <description>CONCLUSIONS:NMS should be considered as a rare complication of therapy with antipsychotics and agents that alter dopamine activity, especially in patients with a history of the syndrome. Careful consideration should be given regarding the risks and benefits of using non-antipsychotic dopamine antagonists in patients with a history of antipsychotic-induced NMS.
    PMID: 21972252 [PubMed - as supplied by publisher] (Source: The Annals of Pharmacotherapy)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>The Annals of Pharmacotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5301749</comments>
            <pubDate>Tue, 04 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5301749</guid>        </item>
        <item>
            <title>Acute drug administration in epilepsy: a review.</title>
            <link>http://www.medworm.com/index.php?rid=5280135&amp;cid=c_33599_168_f&amp;fid=37274&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951369%26dopt%3DAbstract</link>
            <description>Conclusions: The best evidence for the efficacy of ADA exists in febrile and nonfebrile childhood seizures, whereas the evidence in catamenial epilepsy is weak. Prevention of clusters is a well-proven principle but its application has been little studied. Prevention of imminent seizures predicted by well-established triggers, defined risk factors, or premonitory minor seizure activity seems to be at the same time the most intelligent and the least investigated application of ADA and would deserve to be better studied.
    PMID: 21951369 [PubMed - in process] (Source: CNS Neuroscience and Therapeutics)</description>
            <author>CNS Neuroscience and Therapeutics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5280135</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5280135</guid>        </item>
        <item>
            <title>Current perceptions and practices surrounding the recognition and treatment of delirium in the intensive care unit: a survey of 250 critical care pharmacists from eight States.</title>
            <link>http://www.medworm.com/index.php?rid=5301755&amp;cid=c_33599_13_f&amp;fid=37308&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21934036%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Current practices and perceptions surrounding recognition and treatment of delirium in patients in the ICU by the critical care pharmacists surveyed are heterogeneous. Antipsychotics are frequently recommended by pharmacists for delirium treatment, despite a lack of rigorous evidence to support their use. While pharmacists are ideally suited to lead delirium recognition efforts and provide treatment recommendations in this area, these roles need further elucidation. The optimal pedagogical strategy to support these efforts remains unclear, and the potential impact of pharmacists' efforts on patients' outcomes is unknown.
    PMID: 21934036 [PubMed - in process] (Source: The Annals of Pharmacotherapy)</description>
            <author>The Annals of Pharmacotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5301755</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5301755</guid>        </item>
        <item>
            <title>Treating alcohol withdrawal with oral baclofen: A randomized, double‐blind, placebo‐controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=5311974&amp;cid=c_33599_148_f&amp;fid=33649&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjhm.928</link>
            <description>CONCLUSIONS:We found that the use of baclofen was associated with a significant reduction in the use of high doses of benzodiazepine (lorazepam) in the management of symptomatic AWS. The use of low‐dose baclofen in the management of AWS deserves further study, as reduced dependence on high‐dose benzodiazepines in AWS management could improve patient safety. Journal of Hospital Medicine 2011;6:474–479. © 2011 Society of Hospital Medicine (Source: Journal of Hospital Medicine)</description>
            <author>Journal of Hospital Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5311974</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5311974</guid>        </item>
        <item>
            <title>A new clinical protocol for the pharmacological management of acute behavioural disturbance.</title>
            <link>http://www.medworm.com/index.php?rid=5361757&amp;cid=c_33599_172_f&amp;fid=27195&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21995354%26dopt%3DAbstract</link>
            <description>Conclusion: A simplified protocol makes the pharmacological management of acute behaviour disturbance safer for both patients and staff.
    PMID: 21995354 [PubMed - in process] (Source: Australasian Psychiatry)</description>
            <author>Australasian Psychiatry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361757</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5361757</guid>        </item>
        <item>
            <title>Buprenorphine/naloxone/lorazepam interaction: First report of an interaction, leading to respiratory depression: case report</title>
            <link>http://www.medworm.com/index.php?rid=5238053&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001369%2Fart00038</link>
            <description>(Source: Reactions)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5238053</comments>
            <pubDate>Thu, 22 Sep 2011 07:55:36 +0100</pubDate>
            <guid isPermaLink="false">5238053</guid>        </item>
        <item>
            <title>Letters to BMJ on shortgage of lorazepam injection in UK</title>
            <link>http://www.medworm.com/index.php?rid=5247836&amp;cid=c_33599_172_f&amp;fid=27210&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FNews%2F2011---September%2F22%2FLetters-to-BMJ-on-availability-of-lorazepam%2F</link>
            <description>Source: BMJ
Area: News
 In a letter to the BMJ, the author from Addenbrooke's Hospital notes that hospitals in his area have been out of stock of IV lorazepam since May 2010. He explains why this drug is preferable to IV diazepam as first line treatment of status epilepticus, and expresses concern about the difficulty in treating patients with status epilepticus and those with agitation, as they are being exposed to drugs that are less likely to be successful and have more common and serious adverse events. He notes that there seems to be no problem with supplies in the US and cannot understand why stocks from there cannot be made available to the UK market. He calls on Pfizer to consider releasing sufficient quantities of IV lorazepam to the UK market soon, calling for a detailed explanat...</description>
            <author>NeLM - Mental Health</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5247836</comments>
            <pubDate>Thu, 22 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5247836</guid>        </item>
        <item>
            <title>Where has all the lorazepam gone?</title>
            <link>http://www.medworm.com/index.php?rid=5239434&amp;cid=c_33599_22_f&amp;fid=30413&amp;url=http%3A%2F%2Ffeeds.bmj.com%2F%7Er%2Fbmj%2Frecent%2F%7E3%2FTc0vv42_xws%2Fbmj.d5955.short</link>
            <description>Intravenous lorazepam is preferable to intravenous diazepam as first line treatment of status epilepticus.1 It has a longer redistribution half life, which lessens the chance of seizure recurrence.1... (Source: BMJ Online First)</description>
            <author>BMJ Online First</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5239434</comments>
            <pubDate>Wed, 21 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5239434</guid>        </item>
        <item>
            <title>Pfizer's reply to de Monteverde-Robb</title>
            <link>http://www.medworm.com/index.php?rid=5239436&amp;cid=c_33599_22_f&amp;fid=30413&amp;url=http%3A%2F%2Ffeeds.bmj.com%2F%7Er%2Fbmj%2Frecent%2F%7E3%2FKmVBs_3Yhds%2Fbmj.d5962.short</link>
            <description>For several months Pfizer has faced supply issues with its intravenous preparation of lorazepam (Ativan), which until recently has been produced by a third party manufacturer, Recipharm, on behalf of... (Source: BMJ Online First)</description>
            <author>BMJ Online First</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5239436</comments>
            <pubDate>Wed, 21 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5239436</guid>        </item>
        <item>
            <title>Risk of Fractures Requiring Hospitalization After an Initial Prescription for Zolpidem, Alprazolam, Lorazepam, or Diazepam in Older Adults</title>
            <link>http://www.medworm.com/index.php?rid=5249670&amp;cid=c_33599_18_f&amp;fid=28409&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1532-5415.2011.03591.x</link>
            <description>ConclusionIn older adults, the risk of injury with zolpidem exceeded that with alprazolam and lorazepam and was similar to that with diazepam. If the associations are causal, then the high incidence of these fractures implies that these treatment induce a substantial number of fractures and consequential costs. Further study of the association is imperative. (Source: Journal of the American Geriatrics Society)</description>
            <author>Journal of the American Geriatrics Society</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5249670</comments>
            <pubDate>Wed, 21 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5249670</guid>        </item>
        <item>
            <title>Current Perceptions and Practices Surrounding the Recognition and Treatment of Delirium in the Intensive Care Unit: A Survey of 250 Critical Care Pharmacists from Eight States (October).</title>
            <link>http://www.medworm.com/index.php?rid=5266894&amp;cid=c_33599_13_f&amp;fid=37308&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21934036%26dopt%3DAbstract</link>
            <description>CONCLUSIONS:Current practices and perceptions surrounding recognition and treatment of delirium in patients in the ICU by the critical care pharmacists surveyed are heterogeneous. Antipsychotics are frequently recommended by pharmacists for delirium treatment, despite a lack of rigorous evidence to support their use. While pharmacists are ideally suited to lead delirium recognition efforts and provide treatment recommendations in this area, these roles need further elucidation. The optimal pedagogical strategy to support these efforts remains unclear, and the potential impact of pharmacists' efforts on patients' outcomes isunknown.
    PMID: 21934036 [PubMed - as supplied by publisher] (Source: The Annals of Pharmacotherapy)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>The Annals of Pharmacotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5266894</comments>
            <pubDate>Tue, 20 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5266894</guid>        </item>
        <item>
            <title>Bladder Rupture After Intentional Medication Overdose. - Huston B, Mills K, Froloff V, McGee M.</title>
            <link>http://www.medworm.com/index.php?rid=5216032&amp;cid=c_33599_46_f&amp;fid=34959&amp;url=http%3A%2F%2Fwww.safetylit.org%2Fcitations%2Findex.php%3Ffuseaction%3Dcitations.viewdetails%26citationIds%5B%5D%3Dcitjournalarticle_314578_1</link>
            <description>We report the case of a 51-year-old woman who had a medical history of diabetes, depression with past suicide attempts, and suicidal ideation. She was found unresponsive in a motel with multiple bottles of medicines (melatonin, carisoprodol, ativan, and cl... (Source: SafetyLit: All (Unduplicated))</description>
            <author>SafetyLit: All (Unduplicated)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5216032</comments>
            <pubDate>Wed, 14 Sep 2011 01:00:09 +0100</pubDate>
            <guid isPermaLink="false">5216032</guid>        </item>
        <item>
            <title>Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study</title>
            <link>http://www.medworm.com/index.php?rid=5211150&amp;cid=c_33599_25_f&amp;fid=33364&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff108t80516632219%2F</link>
            <description>We report a randomized, open labeled pilot study comparing
 the efficacy and safety of LEV and LOR in SE. Consecutive patients with convulsive or subtle convulsive SE were randomized
 to LEV 20&amp;nbsp;mg/kg IV over 15&amp;nbsp;min or LOR 0.1&amp;nbsp;mg/kg over 2–4&amp;nbsp;min. Failure to control SE within 10&amp;nbsp;min of administration of one
 study drug was treated by the other study drug. The primary endpoint was clinical seizure cessation and secondary endpoints
 were 24&amp;nbsp;h freedom from seizure, hospital mortality, and adverse events. Our results are based on 79 patients. Both LEV and
 LOR were equally effective. In the first instance, the SE was controlled by LEV in 76.3% (29/38) and by LOR in 75.6% (31/41)
 of patients. In those resistant to the above regimen, LEV controlled SE in 70.0% (7/1...</description>
            <author>Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5211150</comments>
            <pubDate>Tue, 06 Sep 2011 15:51:31 +0100</pubDate>
            <guid isPermaLink="false">5211150</guid>        </item>
        <item>
            <title>GABAA Receptor Modulation During Adolescence Alters Adult Ethanol Intake and Preference in Rats</title>
            <link>http://www.medworm.com/index.php?rid=5205992&amp;cid=c_33599_2_f&amp;fid=17956&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1530-0277.2011.01622.x</link>
            <description>Conclusions:  These data demonstrate that GABAA receptor modulation during adolescence can alter intake and preference for ethanol in adulthood and highlights the importance of drug history as an important variable in the liability for alcohol abuse. (Source: Alcoholism: Clinical and Experimental Research)</description>
            <author>Alcoholism: Clinical and Experimental Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5205992</comments>
            <pubDate>Tue, 06 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5205992</guid>        </item>
        <item>
            <title>GABA(A) Receptor Modulation During Adolescence Alters Adult Ethanol Intake and Preference in Rats.</title>
            <link>http://www.medworm.com/index.php?rid=5219502&amp;cid=c_33599_2_f&amp;fid=37664&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21895721%26dopt%3DAbstract</link>
            <description>Conclusions:  These data demonstrate that GABA(A) receptor modulation during adolescence can alter intake and preference for ethanol in adulthood and highlights the importance of drug history as an important variable in the liability for alcohol abuse.
    PMID: 21895721 [PubMed - as supplied by publisher] (Source: Alcoholism, Clinical and Experimental Research)</description>
            <author>Alcoholism, Clinical and Experimental Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5219502</comments>
            <pubDate>Tue, 06 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5219502</guid>        </item>
        <item>
            <title>Benzodiazepine Use in Breast Cancer Survivors: Findings from a Consecutive Series of 1,000 Patients.</title>
            <link>http://www.medworm.com/index.php?rid=5219804&amp;cid=c_33599_6_f&amp;fid=36423&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21894050%26dopt%3DAbstract</link>
            <description>Conclusion: Anxiety appears to be a common explanation for relatively high rates of benzodiazepine use in breast cancer survivors. This finding merits further study.
    PMID: 21894050 [PubMed - as supplied by publisher] (Source: Oncology)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5219804</comments>
            <pubDate>Fri, 02 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5219804</guid>        </item>
        <item>
            <title>Psychogenic Unresponsiveness</title>
            <link>http://www.medworm.com/index.php?rid=5349684&amp;cid=c_33599_25_f&amp;fid=33237&amp;url=http%3A%2F%2Fwww.neurologic.theclinics.com%2Farticle%2FPIIS0733861911000521%2Fabstract%3Frss%3Dyes</link>
            <description>Unresponsive patients with or without catatonic motor signs are etiologically heterogeneous, and all require a comprehensive neurodiagnostic assessment to rule out organic causes. Most cases prove to be due to primary psychiatric disorders, mostly mood disorders, especially mania, rather than schizophrenia. These patients respond to lorazepam administered by any route and, failing this, electroconvulsive therapy. Those patients with associated fever and autonomic instability are medical emergencies and need urgent treatment. (Source: Neurologic Clinics)</description>
            <author>Neurologic Clinics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5349684</comments>
            <pubDate>Fri, 02 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5349684</guid>        </item>
        <item>
            <title>Detection and validated quantification of 21 benzodiazepines and 3 “z-drugs” in human hair by LC–MS/MS</title>
            <link>http://www.medworm.com/index.php?rid=5657456&amp;cid=c_33599_142_f&amp;fid=35576&amp;url=http%3A%2F%2Fwww.fsijournal.org%2Farticle%2FPIIS0379073811003951%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: A method for detection and quantification of 21 benzodiazepines and the pharmacologically related “z-drugs” in human hair samples was developed and fully validated using liquid chromatography coupled to tandem mass spectrometry (LC–MS/MS). After methanolic and methanolic/aqueous extraction, the analytes were separated using two different LC–MS systems (AB Sciex 3200 QTRAP and AB Sciex 5500 QTRAP). Separation columns, mobile phases and MS modes for both systems were: Phenomenex Kinetex, 2.6μm, 50/2.1; 5mM ammonium formate buffer pH 3.5/methanol, total flow 0.75mL/min; electrospray ionization (ESI), multiple reaction monitoring (MRM), information dependent acquisition (IDA), enhanced product ion scan (EPI). The assays were found to be selective for the tested compounds (al...</description>
            <author>Forensic Science International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5657456</comments>
            <pubDate>Mon, 29 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5657456</guid>        </item>
        <item>
            <title>Carbamazepine reduces short-interval interhemispheric inhibition in healthy humans</title>
            <link>http://www.medworm.com/index.php?rid=5579109&amp;cid=c_33599_168_f&amp;fid=38452&amp;url=http%3A%2F%2Fwww.clinph-journal.com%2Farticle%2FPIIS1388245711005281%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: We conclude that circuits mediating short interstimulus intervals of IHI are susceptible to sodium channel blockade.Significance: The results increase our knowledge of interhemispheric transmission. (Source: Clinical Neurophysiology)</description>
            <author>Clinical Neurophysiology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5579109</comments>
            <pubDate>Mon, 22 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5579109</guid>        </item>
        <item>
            <title>Carbamazepine reduces short-interval interhemispheric inhibition in healthy humans.</title>
            <link>http://www.medworm.com/index.php?rid=5164493&amp;cid=c_33599_25_f&amp;fid=35404&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21862399%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: We conclude that circuits mediating short interstimulus intervals of IHI are susceptible to sodium channel blockade. SIGNIFICANCE: The results increase our knowledge of interhemispheric transmission.
    PMID: 21862399 [PubMed - as supplied by publisher] (Source: Clinical Neurophysiology)</description>
            <author>Clinical Neurophysiology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5164493</comments>
            <pubDate>Thu, 18 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5164493</guid>        </item>
        <item>
            <title>Pharmacokinetics of buccal and intranasal lorazepam in healthy adult volunteers</title>
            <link>http://www.medworm.com/index.php?rid=5132303&amp;cid=c_33599_13_f&amp;fid=33420&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg174641p31146554%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Intranasal lorazepam has more favourable pharmacokinetics than buccal lorazepam when considering the need for the rapid blood
 concentrations required for seizure termination. Further clinical evaluation of this route is required.
 
 
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s00228-011-1109-1Authors
		Mark Anderson, Great North Children’s Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP UKParag Tambe, Academic Division of Child Health, University of Nottingham, Derbyshire Children’s Hospital, Derby, UKHelen Sammons, Academic Division of Child Health, University of Nottingham, Derbyshire Children’s Hospital, Derby, UKHussain Mulla, Centre for Therapeutic Evaluation of Drugs in Children, ...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>European Journal of Clinical Pharmacology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5132303</comments>
            <pubDate>Fri, 12 Aug 2011 06:14:59 +0100</pubDate>
            <guid isPermaLink="false">5132303</guid>        </item>
        <item>
            <title>Lorazepam withdrawal: Withdrawal symptoms and delirium: case report</title>
            <link>http://www.medworm.com/index.php?rid=5109776&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001363%2Fart00109</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5109776</comments>
            <pubDate>Wed, 10 Aug 2011 17:36:32 +0100</pubDate>
            <guid isPermaLink="false">5109776</guid>        </item>
        <item>
            <title>Buspirone/duloxetine/lorazepam/sulpiride overdose: Bezoar formation leading to esophageal obstruction (first report for sulpiride, buspirone and duloxetine): case report</title>
            <link>http://www.medworm.com/index.php?rid=5079723&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001362%2Fart00034</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5079723</comments>
            <pubDate>Mon, 01 Aug 2011 15:09:42 +0100</pubDate>
            <guid isPermaLink="false">5079723</guid>        </item>
        <item>
            <title>Lorazepam: Respiratory distress: case report</title>
            <link>http://www.medworm.com/index.php?rid=5058348&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001361%2Fart00101</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5058348</comments>
            <pubDate>Sun, 24 Jul 2011 19:59:43 +0100</pubDate>
            <guid isPermaLink="false">5058348</guid>        </item>
        <item>
            <title>Haloperidol/lorazepam/valproic acid: Fatal myocardial infarction: case report</title>
            <link>http://www.medworm.com/index.php?rid=5021043&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001359%2Fart00069</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5021043</comments>
            <pubDate>Wed, 13 Jul 2011 16:51:36 +0100</pubDate>
            <guid isPermaLink="false">5021043</guid>        </item>
        <item>
            <title>Lorazepam withdrawal: With drawal symptoms, treated wtih agomelatine: case report</title>
            <link>http://www.medworm.com/index.php?rid=5021068&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001359%2Fart00094</link>
            <description>(Source: Reactions)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5021068</comments>
            <pubDate>Wed, 13 Jul 2011 16:51:36 +0100</pubDate>
            <guid isPermaLink="false">5021068</guid>        </item>
        <item>
            <title>Safety assessment of potentially inappropriate medications use in older people and the factors associated with hospital admission.</title>
            <link>http://www.medworm.com/index.php?rid=5013115&amp;cid=c_33599_13_f&amp;fid=32523&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21733416%26dopt%3DAbstract</link>
            <description>Conclusion: PIM use in elderly people is not a risk factor for ADR-related hospital admission. Probably, severe ADR, which lead to hospitalizations of older people, can be explained by idiosyncratic response or the predisposition of these patients to develop adverse drug events, whether or not drugs are classed as PIM. Key-words: potentially inappropriate medication (PIM), older people, adverse drug reaction (ADR), hospital admission, pharmacovigilance.
    PMID: 21733416 [PubMed - in process] (Source: J Pharm Pharm Sci)</description>
            <author>J Pharm Pharm Sci</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5013115</comments>
            <pubDate>Tue, 12 Jul 2011 15:30:03 +0100</pubDate>
            <guid isPermaLink="false">5013115</guid>        </item>
        <item>
            <title>Drug induced immune haemolytic anaemia in the Berlin Case‐Control Surveillance Study</title>
            <link>http://www.medworm.com/index.php?rid=5021737&amp;cid=c_33599_19_f&amp;fid=29464&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2141.2011.08784.x</link>
            <description>This study investigated the possibility of drug aetiology of immune haemolytic anaemia (IHA) in 134 patients with new onset of IHA who were identified in the Berlin Case‐Control Surveillance Study between 2000 and 2009. Single drugs related to IHA in three or more patients and assessed more than once as a certain or probable cause of IHA in a standardized causality assessment included diclofenac, fludarabine, oxaliplatin, ceftriaxone and piperacillin. In a case‐control study including all 124 IHA cases developed in outpatient care and 731 controls, significantly increased odds ratios (OR) were observed for beta‐lactam antibiotics (OR = 8·8; 95% confidence interval [CI] 3·2–25·2), cotrimoxazole (OR = 6·5; CI 1·1–37·9), ciprofloxacin (OR = 6·9, CI 1·3–38·5), ...</description>
            <author>British Journal of Haematology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5021737</comments>
            <pubDate>Mon, 11 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5021737</guid>        </item>
        <item>
            <title>MF.04 Effects placebo of and lorazepam on emotional voice processing: An fMRI study</title>
            <link>http://www.medworm.com/index.php?rid=5007452&amp;cid=c_33599_153_f&amp;fid=32209&amp;url=http%3A%2F%2Fjnnp.bmj.com%2Fcgi%2Fcontent%2Fshort%2F82%2F8%2Fe2-o%3Frss%3D1</link>
            <description>Conclusions
Our results suggest that cerebral response in bilateral IFG and anterior insula is closely related to common anti-anxiety effect of both placebo and lorazepam. Increased left BA8 activation compared with lorazepam may reflect the anti-anxiety effect of placebo. (Source: Journal of Neurology, Neurosurgery and Psychiatry)</description>
            <author>Journal of Neurology, Neurosurgery and Psychiatry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5007452</comments>
            <pubDate>Wed, 06 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5007452</guid>        </item>
        <item>
            <title>Intravenous Diazepam, Midazolam and Lorazepam in Acute Seizure Control</title>
            <link>http://www.medworm.com/index.php?rid=4988196&amp;cid=c_33599_33_f&amp;fid=35971&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F48430l3l01189tx6%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;All the three groups were comparable in terms of time to clinical seizure cessation, seizure recurrence and uncontrolled seizures
 after drug administration. However, number of patients requiring second dose to control seizures were significantly higher
 in diazepam group when compared to lorazepam group. Excessive somnolence and sedation occurred more frequently with diazepam.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s12098-011-0505-yAuthors
		Geeta Gathwala, Departments of Pediatrics, Pt. B.D.Sharma PGIMS, University of Health Sciences Rohtak, 6J/8, Medical Enclave, Rohtak, 124001 Haryana, IndiaMayank Goel, Departments of Pediatrics, Pt. B.D.Sharma PGIMS, University of Health Sciences Rohtak, 6J/8, Medical Enclave, Rohtak, 124001 Haryana, IndiaJagj...</description>
            <author>Indian Journal of Pediatrics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4988196</comments>
            <pubDate>Wed, 29 Jun 2011 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">4988196</guid>        </item>
        <item>
            <title>Benefit of cognitive-behavior therapy alongside pharmacotherapy in treating obsessive-compulsive disorder with depression: a case report and review of the literature</title>
            <link>http://www.medworm.com/index.php?rid=5034327&amp;cid=c_33599_44_f&amp;fid=39314&amp;url=http%3A%2F%2Fwww.ijsronline.com%2Findex.php%2FIJSR%2Farticle%2Fview%2F104</link>
            <description>We present a challenging case highlighting the benefit of CBT alongside medication adjustments in a mental health unit. A 20-year-old male patient presented to our mental health unit with previously diagnosed OCD and severe depression. In addition, he also had social anxiety, insomnia, and suicidal ideation. Patient history revealed that he had been prescribed fluvoxamine, 200 mg per day, five months back but his symptoms had gotten worse. He has had one previous hospitalization. His Global Assessment of Functioning (GAF) at admission was in the range of 21-30. The fluvoxamine that had been previously prescribed was kept at 200 mg per day. In addition, he was also prescribed lorazepam 1 mg every four hours (anxiety), and zolpidem 10 mg per day (insomnia). During his inpatient stay, the pat...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>International Journal of Students Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5034327</comments>
            <pubDate>Mon, 27 Jun 2011 06:03:55 +0100</pubDate>
            <guid isPermaLink="false">5034327</guid>        </item>
        <item>
            <title>Intranasal administration safe and effective for selected drugs</title>
            <link>http://www.medworm.com/index.php?rid=4958608&amp;cid=c_33599_57_f&amp;fid=39029&amp;url=http%3A%2F%2Fwww.thepoisonreview.com%2F2011%2F06%2F21%2Fintranasal-administration-safe-and-effective-for-selected-drugs%2F</link>
            <description>4 out of 5 stars
Intranasal Drug Administration: An Innovative Approach to Traditional Care. Collopy KT, Snyder S. EMS World 2011 May;40:45-50.
Abstract
The intranasal (IN) route provides a safe, efficient way of delivering certain medications when an intravenous line is not in place. This review article is worth reading for an overview of the topic, despite some sketchiness in describing exact technique.
The nasal mucosa provide over 180 cm2 of absorptive surface area. The turbinates are highly vascular and provide direct access to the central nervous system, avoiding first-pass metabolism.  The use of spray-tipped atomizers allows drug to be administered rapidly, with the head in any position.
The advantages of IN administration include rapid onset (especially of drugs that act on the C...</description>
            <author>The Poison Review</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4958608</comments>
            <pubDate>Tue, 21 Jun 2011 17:59:46 +0100</pubDate>
            <guid isPermaLink="false">4958608</guid>        </item>
        <item>
            <title>Adult age and ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjects</title>
            <link>http://www.medworm.com/index.php?rid=4937196&amp;cid=c_33599_13_f&amp;fid=32540&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2125.2011.04036.x</link>
            <description>Conclusions: There was no association of adult age with ex vivo fu of lorazepam, oxazepam or temazepam in healthy subjects. (Source: British Journal of Clinical Pharmacology)</description>
            <author>British Journal of Clinical Pharmacology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4937196</comments>
            <pubDate>Mon, 13 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4937196</guid>        </item>
        <item>
            <title>Treatment for Abuse of Anti-Anxiety Drugs Tripled Over 10 Years</title>
            <link>http://www.medworm.com/index.php?rid=4914215&amp;cid=c_33599_13_f&amp;fid=36948&amp;url=http%3A%2F%2Fwww.doctorslounge.com%2Findex.php%2Fnews%2Fhd%2F20760</link>
            <description>Misuse of Valium, Ativan and other benzodiazepines is a growing problem, report finds (Source: Pharmacy News - Doctors Lounge)</description>
            <author>Pharmacy News - Doctors Lounge</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4914215</comments>
            <pubDate>Thu, 09 Jun 2011 14:00:00 +0100</pubDate>
            <guid isPermaLink="false">4914215</guid>        </item>
        <item>
            <title>LORAZEPAM (Lorazepam) Tablet [AvPAK]</title>
            <link>http://www.medworm.com/index.php?rid=4913994&amp;cid=c_33599_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D45150</link>
            <description>Updated Date: Jun 8, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4913994</comments>
            <pubDate>Wed, 08 Jun 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">4913994</guid>        </item>
        <item>
            <title>[Hypothermia under olanzapine treatment : Clinical case series and review of current literature.]</title>
            <link>http://www.medworm.com/index.php?rid=4925326&amp;cid=c_33599_25_f&amp;fid=36790&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21626387%26dopt%3DAbstract</link>
            <description>CONCLUSION: A review of the current literature reveals that thermoregulatory disturbances as sequelae of antipsychotic drug administration depend on individual disposition as well as various independent risk factors such as environmental temperature, somatic comorbidities, endocrinological abnormalities (e.g. hypothyroidism) and structural damage of the brain. A complex interaction of dopaminergic regulatory mechanisms in the ventral hypothalamus and peripheral vaso- and sudomotor adjustments seems to be causative. Hypothermia following antipsychotic drug administration represents a serious adverse drug reaction and a potentially life-threatening event.
    PMID: 21626387 [PubMed - as supplied by publisher] (Source: Der Nervenarzt)</description>
            <author>Der Nervenarzt</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4925326</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4925326</guid>        </item>
        <item>
            <title>Bipolar Disorder in the News - 5/23/11</title>
            <link>http://www.medworm.com/index.php?rid=4862347&amp;cid=c_33599_172_f&amp;fid=38331&amp;url=http%3A%2F%2Fbipolar.about.com%2Fb%2F2011%2F05%2F23%2Fbipolar-disorder-in-the-news-52311.htm</link>
            <description>Here's a headline I really hated: &quot;Bipolar banker blows millions, gets jail time.&quot; The actual point of the story was that this guy who lost millions of Euros for his Austrian bank and its customers got a reduced sentence because his having BP constituted &quot;extenuating circumstances.&quot; He was sentenced to three years in prison but only has to serve one. The critical unanswered question is, when was he diagnosed? If it was before all this started, and the bipolar affected his behavior - I'd need to know a lot more about the circumstances. Was he off his meds? Was he avoiding his doctor? Was his doctor incompetent? (I'm also wondering why an embezzler got only three years in the first place.)

Next there's a judge in Australia whose &quot;admittedly inappropriate behavior&quot; in court was due to undiag...</description>
            <author>About.com Bipolar Disorder</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4862347</comments>
            <pubDate>Mon, 23 May 2011 16:41:51 +0100</pubDate>
            <guid isPermaLink="false">4862347</guid>        </item>
        <item>
            <title>Labetalol/lorazepam overdose: Hypotension and bradycardia in a hypothermic patient: case report</title>
            <link>http://www.medworm.com/index.php?rid=4720367&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001347%2Fart00084</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4720367</comments>
            <pubDate>Sat, 16 Apr 2011 17:06:15 +0100</pubDate>
            <guid isPermaLink="false">4720367</guid>        </item>
        <item>
            <title>Lorazepam overdose/flumazenil: Coma followed by ventricular tachycardia: case report</title>
            <link>http://www.medworm.com/index.php?rid=4698659&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001346%2Fart00084</link>
            <description>(Source: Reactions)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4698659</comments>
            <pubDate>Tue, 12 Apr 2011 16:15:37 +0100</pubDate>
            <guid isPermaLink="false">4698659</guid>        </item>
        <item>
            <title>Subacute encephalopathy and seizures in alcoholics (SESA) presenting with non-convulsive status epilepticus</title>
            <link>http://www.medworm.com/index.php?rid=4915615&amp;cid=c_33599_25_f&amp;fid=38650&amp;url=http%3A%2F%2Fwww.seizure-journal.com%2Farticle%2FPIIS1059131111000641%2Fabstract%3Frss%3Dyes</link>
            <description>We report a case of SESA with non-convulsive status epilepticus in a patient who was initially suspected of having a typical alcohol withdrawal seizure.A 61 year old woman with a history of chronic alcoholism was admitted at an outside hospital for confusion thought to be secondary to an alcohol withdrawal seizure. She had right hemiparesis and later developed right facial twitching that did not respond to intravenous fosphenytoin and levetiracetam. She was transferred for further management. Upon arrival, lorazepam and fosphenytoin were given and right face clonic movements resolved. However, continuous EEG monitoring revealed ongoing non-convulsive status epilepticus (NCSE). Following treatment with IV valproate and lacosamide, there was resolution of NCSE.SESA is likely an under recogni...</description>
            <author>Seizure: European Journal of Epilepsy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4915615</comments>
            <pubDate>Sun, 03 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4915615</guid>        </item>
        <item>
            <title>Diazepam/lorazepam/oxazepam withdrawal: Hyperalgesia: 4 case reports</title>
            <link>http://www.medworm.com/index.php?rid=4616920&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001343%2Fart00052</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4616920</comments>
            <pubDate>Tue, 22 Mar 2011 17:01:08 +0100</pubDate>
            <guid isPermaLink="false">4616920</guid>        </item>
        <item>
            <title>Misery of the tranquilliser addicts forced to go cold turkey by GPs</title>
            <link>http://www.medworm.com/index.php?rid=4617976&amp;cid=c_33599_26_f&amp;fid=23269&amp;url=http%3A%2F%2Fwww.dailymail.co.uk%2Fhealth%2Farticle-1368666%2FMisery-tranquilliser-addicts-forced-cold-turkey-GPs.html%3FITO%3D1490</link>
            <description>There is an estimated 1.3 million Britons addicted to prescription tranquillisers, also known as benzodiazepines. These drugs include diazepam (known previously as Valium), Xanax, Ativan, Serax and Librium. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4617976</comments>
            <pubDate>Tue, 22 Mar 2011 02:32:10 +0100</pubDate>
            <guid isPermaLink="false">4617976</guid>        </item>
        <item>
            <title>[Do urine tests for drugs of abuse cover the substances of interest?]</title>
            <link>http://www.medworm.com/index.php?rid=4723476&amp;cid=c_33599_22_f&amp;fid=36109&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21423307%26dopt%3DAbstract</link>
            <description>This study indicates that most drugs of abuse are detected by common routine urine analyses. Laboratories that offer analyses of drugs of abuse in urine should have methods available to detect pregabalin and methylphenidate in addition to or included in the standard panel.
    PMID: 21423307 [PubMed - as supplied by publisher] (Source: Tidsskrift for den Norske Laegeforening)</description>
            <author>Tidsskrift for den Norske Laegeforening</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4723476</comments>
            <pubDate>Fri, 18 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4723476</guid>        </item>
        <item>
            <title>Bromisoval/lorazepam overdose: Heart arrest and death: case report</title>
            <link>http://www.medworm.com/index.php?rid=4578538&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001342%2Fart00032</link>
            <description>(Source: Reactions)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4578538</comments>
            <pubDate>Sun, 13 Mar 2011 17:03:03 +0100</pubDate>
            <guid isPermaLink="false">4578538</guid>        </item>
        <item>
            <title>Lorazepam: Apnoea: case report</title>
            <link>http://www.medworm.com/index.php?rid=4578588&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001342%2Fart00082</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4578588</comments>
            <pubDate>Sun, 13 Mar 2011 17:03:03 +0100</pubDate>
            <guid isPermaLink="false">4578588</guid>        </item>
        <item>
            <title>Venlafaxine bezoar causing intestinal necrosis</title>
            <link>http://www.medworm.com/index.php?rid=4573971&amp;cid=c_33599_57_f&amp;fid=39029&amp;url=http%3A%2F%2Fwww.thepoisonreview.com%2F2011%2F03%2F11%2Fvenlafaxine-bezoar-causing-intestinal-necrosis%2F</link>
            <description>4 out of 5 stars
Venlafaxine Pharmacobezoar Causing Intestinal Ischemia Requiring Emergency Hemicolectomy. Lung D et a. J Med Toxicol 2011 Mar 4. [Epub ahead of print]
Full Text
Yesterday we discussed the humongous review of pharmacobezoars that appears in the current issue of Clinical Toxicology.  This morning, while trolling through PubMed, I came across this spectacular case report recently posted online before publication.
The report describes a 28-year-old woman who ingested up to 10 g of venlafaxine ER tablets.  At 5 hours after ingestion she had mild tachycardia but was asymptomatic except for tremulousness.  She was treated with lorazepam and a single 100 g dose of activated charcoal; no other GI decontamination was carried out because of concern for possible seizures.  Twenty-...</description>
            <author>The Poison Review</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4573971</comments>
            <pubDate>Fri, 11 Mar 2011 19:09:59 +0100</pubDate>
            <guid isPermaLink="false">4573971</guid>        </item>
        <item>
            <title>Procalcitonin and C-reactive protein levels at admission as predictors of duration of acute brain dysfunction in critically ill patients</title>
            <link>http://www.medworm.com/index.php?rid=4539621&amp;cid=c_33599_53_f&amp;fid=28800&amp;url=http%3A%2F%2Fccforum.com%2Fcontent%2F15%2F2%2FR78</link>
            <description>Conclusions:
In our pilot study, high baseline inflammatory biomarkers predicted prolonged periods of acute brain dysfunction, implicating inflammation as an important mechanism in the pathophysiology of delirium and coma during critical illness, irrespective of whether patients had sepsis or not. (Source: Critical Care)</description>
            <author>Critical Care</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4539621</comments>
            <pubDate>Wed, 02 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4539621</guid>        </item>
        <item>
            <title>The Possible Consequences of Combining Lorazepam and Buprenorphine/Naloxone: A Case Review</title>
            <link>http://www.medworm.com/index.php?rid=4583835&amp;cid=c_33599_27_f&amp;fid=37688&amp;url=http%3A%2F%2Fwww.jenonline.org%2Farticle%2FPIIS0099176710005945%2Fabstract%3Frss%3Dyes</link>
            <description>Administering a benzodiazepine depressant to patients taking buprenorphine/naloxone can be life-threatening. Unfortunately, many ED health care providers are unaware of this potentially lethal combination. The following case study illustrates how these medications, when administered together, can adversely affect patient outcome. (Source: Journal of Emergency Nursing: JEN)</description>
            <author>Journal of Emergency Nursing: JEN</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4583835</comments>
            <pubDate>Tue, 01 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4583835</guid>        </item>
        <item>
            <title>Amitriptyline/lorazepam: Delirium in elderly patients: 2 case reports</title>
            <link>http://www.medworm.com/index.php?rid=4525508&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001340%2Fart00023</link>
            <description>(Source: Reactions)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4525508</comments>
            <pubDate>Sun, 27 Feb 2011 18:11:29 +0100</pubDate>
            <guid isPermaLink="false">4525508</guid>        </item>
        <item>
            <title>ATIVAN (Lorazepam) Tablet [STAT RX USA LLC]</title>
            <link>http://www.medworm.com/index.php?rid=4478579&amp;cid=c_33599_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D38750</link>
            <description>Updated Date: Feb 14, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4478579</comments>
            <pubDate>Mon, 14 Feb 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">4478579</guid>        </item>
        <item>
            <title>LORAZEPAM (Lorazepam) Tablet [Lake Erie Medical DBA Quality Care Products LLC]</title>
            <link>http://www.medworm.com/index.php?rid=4465797&amp;cid=c_33599_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D38561</link>
            <description>Updated Date: Feb 11, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4465797</comments>
            <pubDate>Fri, 11 Feb 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">4465797</guid>        </item>
        <item>
            <title>The Use of Opioids and Sedatives and Time Until Death After Withdrawing Mechanical Ventilation and Vasoactive Drugs in a Dutch Intensive Care Unit.</title>
            <link>http://www.medworm.com/index.php?rid=4482352&amp;cid=c_33599_5_f&amp;fid=28821&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21304154%26dopt%3DAbstract</link>
            <description>Conclusions: Dutch patients who die in the ICU, or die after discharge from the ICU, die after MV and/or VAs are withdrawn. When treatments are withdrawn, death follows within 1 hour in most patients, which is a reflection of the severity of illnesses. At least 80% of patients receive opioids, and 67% receive sedatives until death. Fentanyl is the most used opioid, whereas midazolam is the most used sedative. Dosages of opioids and sedatives did not significantly exceed the ranges described as usual in the international literature.
    PMID: 21304154 [PubMed - as supplied by publisher] (Source: Anesthesia and Analgesia)</description>
            <author>Anesthesia and Analgesia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4482352</comments>
            <pubDate>Tue, 08 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4482352</guid>        </item>
        <item>
            <title>Clinical practice</title>
            <link>http://www.medworm.com/index.php?rid=4456927&amp;cid=c_33599_33_f&amp;fid=33425&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd32h27586223k252%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;An adequate early treatment of a long-lasting convulsive seizure is critical in reducing potential morbidity, and in particular,
 brain damage. In pre-hospital settings the use of benzodiazepines should become standard. Nowadays, rectal diazepam is used
 frequently, but midazoloam and lorazepam are becoming more popular, both being given either intranasally or orally. The buccal
 route is to be preferred because of its easy use and high efficacy. A generally accepted policy for early treatment of convulsive
 seizures is a crucial issue in the elaboration of an overall treatment plan for the child with epilepsy. Such a plan should
 include instruction and education of the parents and the caregivers surrounding the child.
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1...</description>
            <author>European Journal of Pediatrics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4456927</comments>
            <pubDate>Mon, 07 Feb 2011 22:54:31 +0100</pubDate>
            <guid isPermaLink="false">4456927</guid>        </item>
        <item>
            <title>Reduction of temazepam to diazepam and lorazepam to delorazepam during enzymatic hydrolysis.</title>
            <link>http://www.medworm.com/index.php?rid=4456781&amp;cid=c_33599_59_f&amp;fid=37498&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21298417%26dopt%3DAbstract</link>
            <description>In this study, we report that this unusual reductive transformation also occurs in other benzodiazepines with a hydroxyl group at the C3 position such as temazepam and lorazepam. As determined by liquid chromatography-mass spectrometry analysis, all three enzyme preparations were found capable of converting urinary temazepam into diazepam following enzymatic incubation and subsequent liquid-liquid extraction procedures. For example, when H. pomatia enzymes were used with incubation conditions of 18 h and 50 °C, the percentage conversion, although small, was significant-approximately 1% (0.59-1.54%) in both patient and spiked blank urines. Similarly, using H. pomatia enzyme under these incubation conditions, a reductive transformation of urinary lorazepam into delorazepam (chlordesmethyl...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Analytical and Bioanalytical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4456781</comments>
            <pubDate>Sun, 06 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4456781</guid>        </item>
        <item>
            <title>Hiccups as the only symptom of non–ST-segment elevation myocardial infarction</title>
            <link>http://www.medworm.com/index.php?rid=5441573&amp;cid=c_33599_14_f&amp;fid=34435&amp;url=http%3A%2F%2Fwww.ajemjournal.com%2Farticle%2FPIIS0735675710005796%2Fabstract%3Frss%3Dyes</link>
            <description>We present this case report to inform emergency physicians about the potential for hiccups to serve as the only presenting symptom of a myocardial infarction. The patient, a 68-year-old man with a history of diabetes mellitus, hypertension, and current tobacco use, was first seen in the emergency department after 4 days of intractable hiccups with no other complaints or symptoms. After ineffective hiccup treatment on the first visit with 2 mg Ativan and 25 intramuscular (IM) thorazine and a normal chest x-ray, he was discharged. Two days later, the patient returned to the emergency department with the same complaint of hiccups without any additional complaints or symptoms. An electrocardiogram displayed several abnormalities including Q waves in II, III, and aVF and T-wave inversions in aV...</description>
            <author>The American Journal of Emergency Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5441573</comments>
            <pubDate>Mon, 31 Jan 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5441573</guid>        </item>
        <item>
            <title>Intranasal versus intravenous lorazepam for control of acute seizures in children: A randomized open‐label study</title>
            <link>http://www.medworm.com/index.php?rid=4427688&amp;cid=c_33599_25_f&amp;fid=32232&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1528-1167.2010.02949.x</link>
            <description>This study compared the efficacy and adverse effects of intranasal versus intravenous lorazepam in children aged 6–14 years who presented with acute seizures.Methods:  This was a randomized open‐label study conducted at an Indian hospital from August 2008 to April 2009. One hundred forty‐one consecutive children aged 6–14 years who presented convulsing to the emergency room were included. After stabilization, the children were randomized to receive either intravenous or intranasal lorazepam (0.1 mg/kg, maximum 4 mg). The primary outcome measure was clinical seizure remission within 10 min of drug administration. The study was registered with clinicaltrials.gov (NCT00735527).Key Findings:  Seventy patients were randomized to receive intravenous and 71 to receive intran...</description>
            <author>Epilepsia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4427688</comments>
            <pubDate>Fri, 28 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4427688</guid>        </item>
        <item>
            <title>Preventing Medication Dosing Errors For Infants And Children</title>
            <link>http://www.medworm.com/index.php?rid=4394196&amp;cid=c_33599_26_f&amp;fid=23292&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2F2KoGUJO64kc%2F3Qqr</link>
            <description>Preparing small doses of medication from syringes may be inaccurate and can result in crucial dosing errors for infants and children, according to a study published in CMAJ (Canadian Medical Association Journal). Because babies and young children require small doses of drugs, these are often prepared from stock of less than 0.1 mL which can result in dosing errors and possible adverse events. Medications most commonly requiring small doses include potent narcotics and sedatives such as morphine, lorazepam and fentanyl as well as immunosuppressants... (Source: Health News from Medical News Today)</description>
            <author>Health News from Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4394196</comments>
            <pubDate>Tue, 25 Jan 2011 11:00:00 +0100</pubDate>
            <guid isPermaLink="false">4394196</guid>        </item>
        <item>
            <title>ATIVAN (Lorazepam) Tablet [Cardinal Health]</title>
            <link>http://www.medworm.com/index.php?rid=4383500&amp;cid=c_33599_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D37362</link>
            <description>Updated Date: Jan 21, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4383500</comments>
            <pubDate>Fri, 21 Jan 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">4383500</guid>        </item>
        <item>
            <title>Correction: Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=4348640&amp;cid=c_33599_53_f&amp;fid=28800&amp;url=http%3A%2F%2Fccforum.com%2Fcontent%2F15%2F1%2F402</link>
            <description>No description available (Source: Critical Care)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Critical Care</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4348640</comments>
            <pubDate>Fri, 14 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4348640</guid>        </item>
        <item>
            <title>Haloperidol: Neuroleptic malignant syndrome treated with lorazepam and diazepam: case report</title>
            <link>http://www.medworm.com/index.php?rid=4327480&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2011%2F00000001%2F00001333%2Fart00066</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4327480</comments>
            <pubDate>Mon, 10 Jan 2011 13:49:21 +0100</pubDate>
            <guid isPermaLink="false">4327480</guid>        </item>
        <item>
            <title>Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine [PAPERS]</title>
            <link>http://www.medworm.com/index.php?rid=4309413&amp;cid=c_33599_172_f&amp;fid=27089&amp;url=http%3A%2F%2Fbjp.rcpsych.org%2Fcgi%2Fcontent%2Fshort%2F198%2F1%2F51%3Frss%3D1</link>
            <description>Conclusions
 
Inhaled loxapine provided a rapid, well-tolerated acute treatment for 
agitation in people with schizophrenia. (Source: The British Journal of Psychiatry)</description>
            <author>The British Journal of Psychiatry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4309413</comments>
            <pubDate>Mon, 03 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4309413</guid>        </item>
        <item>
            <title>Rapid tranquillization agents for severe behavioural disturbance: a survey of African psychiatrists' prescription patterns.</title>
            <link>http://www.medworm.com/index.php?rid=4341872&amp;cid=c_33599_159_f&amp;fid=36148&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21172904%26dopt%3DAbstract</link>
            <description>Authors: James BO
    Guidelines on the use of rapid tranquillizers for severe behavioural disturbance have changed over the last six decades. This survey reports a minimal change in the prescription patterns among psychiatrists sampled from Africa. Parenteral chlorpromazine and diazepam are still commonly prescribed, the least being intramuscular lorazepam, olanzapine and promethazine. Respondents indicated that drug availability was more likely than prescription preference or cost to influence their choices. They were also equally concerned about the tranquillizer's side effects, its ability to provide rapid and sustained sedation and its ability to calm a patient while awaiting psychiatric assessment.
    PMID: 21172904 [PubMed - in process] (Source: Tropical Doctor)</description>
            <author>Tropical Doctor</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4341872</comments>
            <pubDate>Sat, 01 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4341872</guid>        </item>
        <item>
            <title>One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: Investigation of neural correlates with BOLD MRI</title>
            <link>http://www.medworm.com/index.php?rid=4281166&amp;cid=c_33599_172_f&amp;fid=27156&amp;url=http%3A%2F%2Fjop.sagepub.com%2Fcgi%2Fcontent%2Fabstract%2F25%2F1%2F52%3Frss%3D1</link>
            <description>Benzodiazepine effects on cholecystokinin tetrapeptide (CCK-4)-induced panic attack (PA) in humans are incompletely characterized, in particular on the neurofunctional level. This work explores the effects of lorazepam on brain activity and behavioral and physiological symptoms related to CCK-4-induced PA in healthy volunteers. Twenty-one male volunteers received 1 mg of lorazepam or placebo orally, 2 hours before an injection of 0.9% saline solution followed by 50 &amp;micro;g of CCK-4 during functional magnetic resonance imaging (fMRI) and heart rate recording. Panic attacks were defined using the panic symptom scale (PSS). In addition, the Y1-STAI (state anxiety) and the Bond &amp; Lader Visual Analogue Scale (VAS) were used. Eleven subjects were classified as panickers. CCK-4 induced behav...</description>
            <author>Journal of Psychopharmacology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4281166</comments>
            <pubDate>Wed, 22 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4281166</guid>        </item>
        <item>
            <title>Cyproterone to treat aggressivity in dementia: a clinical case and systematic review</title>
            <link>http://www.medworm.com/index.php?rid=4281176&amp;cid=c_33599_172_f&amp;fid=27156&amp;url=http%3A%2F%2Fjop.sagepub.com%2Fcgi%2Fcontent%2Fabstract%2F25%2F1%2F141%3Frss%3D1</link>
            <description>We present a case and systematic review of the current knowledge about the use of cyproterone acetate to treat aggressivity (excluding hypersexuality related behaviours) in dementia. An 82-year-old man required psychiatric inpatient admission due to agitation and aggressivity and was diagnosed with Alzheimer&amp;rsquo;s disease. After failed trials of atypical antipsychotics (quetiapine 100 mg/day and risperidone 1 mg/day), drugs for dementia (memantine 20 mg/day and rivastigmine 9 mg/day) and benzodiazepines (lorazepam 0.5&amp;ndash;1 mg prn) he was started on cyproterone acetate titrated up to 50 mg twice daily. After two weeks he was calmer and did not express aggressivity. Two months later he was discharged to a community placement where he subsequently remained settled on cyproterone. We revi...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Journal of Psychopharmacology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4281176</comments>
            <pubDate>Wed, 22 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4281176</guid>        </item>
        <item>
            <title>Medications for Autism</title>
            <link>http://www.medworm.com/index.php?rid=4277733&amp;cid=c_33599_172_f&amp;fid=34735&amp;url=http%3A%2F%2Fpsychcentral.com%2Flib%2F2010%2Fmedications-for-autism%2F</link>
            <description>Medications are often used to treat behavioral problems, such as aggression, self-injurious behavior, and severe tantrums, that keep the person with an autism spectrum disorder (&amp;#8220;autism&amp;#8221;) from functioning more effectively at home or school. 
The medications used are those that have been developed to treat similar symptoms in other disorders. Many of these medications are prescribed &amp;#8220;off-label.&amp;#8221; This means they have not been officially approved by the U.S. Food and Drug Administration (FDA) for use in children, but the doctor prescribes the medications if he or she feels they are appropriate for your child. Further research needs to be done to ensure not only the efficacy but the safety of psychotropic agents used in the treatment of children and adolescents.
On Octo...</description>
            <author>Psych Central</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4277733</comments>
            <pubDate>Tue, 21 Dec 2010 21:33:31 +0100</pubDate>
            <guid isPermaLink="false">4277733</guid>        </item>
        <item>
            <title>Metabolism of Benzodiazepine and Non-Benzodiazepine Anxiolytic-Hypnotic Drugs: An Analytical Point of View.</title>
            <link>http://www.medworm.com/index.php?rid=4355324&amp;cid=c_33599_13_f&amp;fid=37008&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21189133%26dopt%3DAbstract</link>
            <description>Authors: Mandrioli R, Mercolini L, Raggi MA
    A review with 132 references. Several kinds of anxiolytic and hypnotic drugs are currently available on the market. Although BZDs are surely the most frequently prescribed among them, several chemically unrelated compounds have been commercialised, which can provide similar or even higher efficacy and tolerability. These drugs can prove useful for patients who are non-responder or intolerant to benzodiazepine treatment, thus giving broader therapeutic options to the clinician. The most important studies on the metabolic characteristics of several non-benzodiazepine anxiolytics and hypnotics are reported and briefly discussed in this review; moreover, the analytical methods related to these studies are also described and commented upon and the...</description>
            <author>Current Drug Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4355324</comments>
            <pubDate>Tue, 21 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4355324</guid>        </item>
        <item>
            <title>Formulation design and optimization of fast disintegrating lorazepam tablets by effervescent method</title>
            <link>http://www.medworm.com/index.php?rid=4260118&amp;cid=c_33599_13_f&amp;fid=33846&amp;url=http%3A%2F%2Fwww.ijpsonline.com%2Ftext.asp%3F2010%2F72%2F4%2F431%2F73911</link>
            <description>SB Shirsand, Sarasija Suresh, LS Jodhana, PV SwamyIndian Journal of Pharmaceutical Sciences 2010 72(4):431-436Fast disintegrating tablets of lorazepam were prepared by effervescent method with a view to enhance patient compliance. A 3&amp;#x0026;#898; full factorial design was applied to investigate the combined effect of two formulation variables: amount of crospovidone and mixture of sodium bicarbonate, citric acid and tartaric acid (effervescent material) on in vitro dispersion time. Crospovidone (2-8&amp;#x0025; w/w) was used as superdisintegrant and mixture of sodium bicarbonate, citric acid and tartaric acid (6-18&amp;#x0025; w/w) was used as effervescent material, along with directly compressible mannitol to enhance mouth feel. The tablets were evaluated for hardness, friability, thickness, dru...</description>
            <author>Indian Journal of Pharmaceutical Sciences</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4260118</comments>
            <pubDate>Tue, 14 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4260118</guid>        </item>
        <item>
            <title>Dyspnoea associated with anxiety—symptomatic therapy with opioids in combination with lorazepam and its effect on ventilation in palliative care patients</title>
            <link>http://www.medworm.com/index.php?rid=4267005&amp;cid=c_33599_6_f&amp;fid=33292&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7h0w75x787344135%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our results showed that the use of O + A was a safe and effective treatment option in this patient group. Signs of respiratory
 depression were not found.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s00520-010-1058-8Authors
		Katri Elina Clemens, Department of Science and Research, Centre for Palliative Medicine, University of Bonn, Malteser Krankenhaus Bonn/Rhein-Sieg, Von-Hompesch-Str. 1, 53123 Bonn, GermanyEberhard Klaschik, Department of Science and Research, Centre for Palliative Medicine, University of Bonn, Malteser Krankenhaus Bonn/Rhein-Sieg, Von-Hompesch-Str. 1, 53123 Bonn, Germany
	

	
		Journal Supportive Care in CancerOnline ISSN 1433-7339Print ISSN 0941-4355 (Source: Supportive Care in Cancer)</description>
            <author>Supportive Care in Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4267005</comments>
            <pubDate>Mon, 13 Dec 2010 21:59:54 +0100</pubDate>
            <guid isPermaLink="false">4267005</guid>        </item>
        <item>
            <title>Status Epilepticus</title>
            <link>http://www.medworm.com/index.php?rid=4251836&amp;cid=c_33599_33_f&amp;fid=35971&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc10014063p378062%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Status epilepticus is a common neurological emergency in childhood and associated with significant morbidity and mortality.
 Status epilepticus (SE) has been defined as continuous seizure activity lasting more than 30&amp;nbsp;min or 2 or more seizures in
 this duration without gaining consciousness between them. However, the operational definition has brought the time down to
 5&amp;nbsp;min. Management can be broadly divided into initial stabilization, seizure termination, and evaluation and treatment of
 the underlying cause. Diagnostic evaluation and seizure control should be achieved simultaneously to improve outcome. Seizure
 termination is achieved by pharmacotherapy. Benzodiazepines are the first line drugs for SE. Commonly used drugs include lorazepam,
 diazepam, and m...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Indian Journal of Pediatrics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4251836</comments>
            <pubDate>Fri, 10 Dec 2010 18:18:22 +0100</pubDate>
            <guid isPermaLink="false">4251836</guid>        </item>
        <item>
            <title>[Stocked medications in emergency physician-based medical services in Germany : Reality and requirements according to guidelines.]</title>
            <link>http://www.medworm.com/index.php?rid=4253688&amp;cid=c_33599_5_f&amp;fid=37060&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21127828%26dopt%3DAbstract</link>
            <description>CONCLUSION: Due to recent treatment recommendations provision with sodium bicarbonate, calcium, magnesium, noradrenaline, adenosine, lorazepam iv, dobutamine and as well with ipratropium bromide and salbutamol (both as liquid preparations for inhalation) should be improved. For the future, a federal uniform minimum standard due to evidence-based principles is desirable.
    PMID: 21127828 [PubMed - as supplied by publisher] (Source: Der Anaesthesist)</description>
            <author>Der Anaesthesist</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4253688</comments>
            <pubDate>Sat, 04 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4253688</guid>        </item>
        <item>
            <title>Endogenous dopamine (DA) competes with the binding of a radiolabeled D3 receptor partial agonist in vivo: A positron emission tomography study</title>
            <link>http://www.medworm.com/index.php?rid=4623802&amp;cid=c_33599_25_f&amp;fid=33785&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fsyn.20891</link>
            <description>AbstractA series of microPET imaging studies were conducted in anesthetized rhesus monkeys using the dopamine D3‐selective partial agonist, [18F]5. There was variable uptake in regions of brain known to express a high density of D3 receptors under baseline conditions. Pretreatment with lorazepam (1 mg/kg, i.v. 30 min) to reduce endogenous dopamine activity before tracer injection resulted in a dramatic increase in uptake in the caudate, putamen, and thalamus, and an increase in the binding potential (BP) values, a measure of D3 receptor binding in vivo. These data indicate that there is a high level of competition between [18F]5 and endogenous dopamine for D3 receptors in vivo. Synapse 2011. © 2011 Wiley‐Liss, Inc. (Source: Synapse)</description>
            <author>Synapse</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4623802</comments>
            <pubDate>Fri, 03 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4623802</guid>        </item>
        <item>
            <title>Ventricular tachycardia due to flumazenil administration.</title>
            <link>http://www.medworm.com/index.php?rid=4514434&amp;cid=c_33599_61_f&amp;fid=38172&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21313895%26dopt%3DAbstract</link>
            <description>In this study we present a patient intoxicated with lorazepam who developed a ventricular tachycardia after receiving flumazenil as therapeutic mean, though the attack was appropriately terminated by administration of a bolus dose of Amiodarone. We believe that the ventricular tachycardia onset in above mentioned case is secondary to Flumazenil administration in susceptible patient with previous history of ischemic heart disease. Ventricular tachycardia has rarely reported as flumazenil side effects.
    PMID: 21313895 [PubMed - in process] (Source: Pakistan Journal of Biological Sciences: PJBS)</description>
            <author>Pakistan Journal of Biological Sciences: PJBS</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4514434</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4514434</guid>        </item>
        <item>
            <title>Alcohol-Related Seizures</title>
            <link>http://www.medworm.com/index.php?rid=4198098&amp;cid=c_33599_14_f&amp;fid=33222&amp;url=http%3A%2F%2Fwww.emed.theclinics.com%2Farticle%2FPIIS0733862710000830%2Fabstract%3Frss%3Dyes</link>
            <description>The term alcohol-related seizures (ARS) is used to refer to all seizures in the aggregate associated with alcohol use, including the subset of alcohol withdrawal seizures (AWS). From 20% to 40% of patients with seizure who present to an emergency department have seizures related to alcohol abuse. However, it is critical to avoid prematurely labeling a seizure as being caused by alcohol withdrawal before performing a careful diagnostic evaluation. Benzodiazepines alone are sufficient to prevent AWS. The alcoholic patient with a documented history of ARS, who experiences a single seizure or a short burst of seizures should be treated with lorazepam, 2 mg intravenously. (Source: Emergency Medicine Clinics of North America)</description>
            <author>Emergency Medicine Clinics of North America</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4198098</comments>
            <pubDate>Thu, 25 Nov 2010 04:44:49 +0100</pubDate>
            <guid isPermaLink="false">4198098</guid>        </item>
        <item>
            <title>Bromisoval/lorazepam overdose: Heart arrest and death: case report</title>
            <link>http://www.medworm.com/index.php?rid=4192060&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2010%2F00000001%2F00001328%2Fart00039</link>
            <description>(Source: Reactions)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4192060</comments>
            <pubDate>Wed, 24 Nov 2010 04:27:18 +0100</pubDate>
            <guid isPermaLink="false">4192060</guid>        </item>
        <item>
            <title>Diazepam as a component of goal-directed sedation in critically ill trauma patients</title>
            <link>http://www.medworm.com/index.php?rid=4702558&amp;cid=c_33599_53_f&amp;fid=33231&amp;url=http%3A%2F%2Fwww.jccjournal.org%2Farticle%2FPIIS0883944110002819%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Based on this limited sample, the use of diazepam as a component of goal-directed therapy appears safe and effective in providing adequate sedation in critically ill trauma patients using an average dosage of 40 mg/d. (Source: Journal of Critical Care)</description>
            <author>Journal of Critical Care</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4702558</comments>
            <pubDate>Wed, 24 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4702558</guid>        </item>
        <item>
            <title>Electroconvulsive Therapy for Pediatric Malignant Catatonia With Cerebellar Dysgenesis</title>
            <link>http://www.medworm.com/index.php?rid=4184835&amp;cid=c_33599_25_f&amp;fid=36866&amp;url=http%3A%2F%2Fwww.pedneur.com%2Farticle%2FPIIS0887899410002791%2Fabstract%3Frss%3Dyes</link>
            <description>Electroconvulsive therapy was successfully used to treat malignant catatonia in a 15-year-old male patient with congenital dysgenesis of the left hemisphere of the cerebellum and hypoplasia of the vermis and left pons due to a presumed cerebral vascular accident in utero. The patient experienced significant motor and communication delays with mild cognitive impairment, but was otherwise in good health until age 15 years, when he developed rigidity, posturing, stupor, unresponsiveness, repetitive self-injurious behaviors, and negativism, as well as autonomic abnormalities including profuse diaphoresis and flushing episodes, thus meeting criteria for malignant catatonia. After initial response to lorazepam, the patient required electroconvulsive therapy for resolution of malignant catatonia....</description>
            <author>Pediatric Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4184835</comments>
            <pubDate>Sat, 20 Nov 2010 08:33:31 +0100</pubDate>
            <guid isPermaLink="false">4184835</guid>        </item>
        <item>
            <title>Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands</title>
            <link>http://www.medworm.com/index.php?rid=4123811&amp;cid=c_33599_53_f&amp;fid=28800&amp;url=http%3A%2F%2Fccforum.com%2Fcontent%2F14%2F6%2FR195</link>
            <description>Conclusions:
Compared to CS, RS significantly decreases the overall costs in the ICU.Trial Registration: Clinicaltrials.gov NCT00158873. (Source: Critical Care)</description>
            <author>Critical Care</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4123811</comments>
            <pubDate>Mon, 01 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4123811</guid>        </item>
        <item>
            <title>Review Finds Ativan Best for Treating Severe Epilepsy</title>
            <link>http://www.medworm.com/index.php?rid=4112205&amp;cid=c_33599_26_f&amp;fid=23286&amp;url=http%3A%2F%2Fwww.cfah.org%2Fhbns%2Farchives%2FgetDocument.cfm%3FdocumentID%3D1160</link>
            <description>The drug Ativan is better than Valium or Dilantin for controlling severe epileptic seizures, according to a new review of studies. 10/27 (Source: Health Behavior News Service)</description>
            <author>Health Behavior News Service</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4112205</comments>
            <pubDate>Fri, 29 Oct 2010 19:49:57 +0100</pubDate>
            <guid isPermaLink="false">4112205</guid>        </item>
        <item>
            <title>Cleanup strategies and advantages in the determination of several therapeutic classes of pharmaceuticals in wastewater samples by SPE-LC-MS/MS.</title>
            <link>http://www.medworm.com/index.php?rid=4106858&amp;cid=c_33599_59_f&amp;fid=37498&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20957470%26dopt%3DAbstract</link>
            <description>Authors: Sousa MA, Gonçalves C, Cunha E, Hajšlová J, Alpendurada MF
    This work describes the development and validation of an offline solid-phase extraction with simultaneous cleanup capability, followed by liquid chromatography-(electrospray ionisation)-ion trap mass spectrometry, enabling the concurrent determination of 23 pharmaceuticals of diverse chemical nature, among the most consumed in Portugal, in wastewater samples. Several cleanup strategies, exploiting the physical and chemical properties of the analytes vs. interferences, alongside with the use of internal standards, were assayed in order to minimise the influence of matrix components in the ionisation efficiency of target analytes. After testing all combinations of adsorbents (normal-phase, ion exchange and mixed compo...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Analytical and Bioanalytical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4106858</comments>
            <pubDate>Tue, 19 Oct 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4106858</guid>        </item>
        <item>
            <title>Differential pharmacological responses of catatonia-like signs in frontotemporal dementia.</title>
            <link>http://www.medworm.com/index.php?rid=4018729&amp;cid=c_33599_25_f&amp;fid=36801&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20859826%26dopt%3DAbstract</link>
            <description>Authors: Lauterbach EC, Sharone Kuppuswamy P, Greenway LL
    Sequential therapeutic trials for catatonoid frontal signs in clinically-evident frontotemporal dementia (n = 2) revealed differential benefits for lorazepam, amantadine, memantine, pramipexole, aripiprazole, quetiapine, citalopram, and donepezil, although certain signs also worsened. Citalopram and donepezil were poorly tolerated. Ramelteon was without effect. While memantine appeared to improve cognition in case 1, this remains to be established by more reliable neuropsychological testing. Parkinsonism (case 2) responded to pramipexole, but not amantadine or levodopa. Possible relationships of catatonoid signs requiring future confirmation include insufficient GABA-A (multiple signs) and D2 (mutism) and excessive NMDA (immobil...</description>
            <author>Neurocase</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4018729</comments>
            <pubDate>Thu, 30 Sep 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4018729</guid>        </item>
        <item>
            <title>Ativan (Lorazepam) - updated on RxList</title>
            <link>http://www.medworm.com/index.php?rid=4005556&amp;cid=c_33599_13_f&amp;fid=38372&amp;url=http%3A%2F%2Fwww.rxlist.com%2Fguide.asp%3Fs%3Drss%26k%3Drxlist_drugs%26a%3D71045</link>
            <description>Ativan (Lorazepam) drug description - FDA approved labeling for prescription drugs and medications at RxList (Source: RxList - New and Updated Drug Monographs)</description>
            <author>RxList - New and Updated Drug Monographs</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4005556</comments>
            <pubDate>Mon, 27 Sep 2010 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">4005556</guid>        </item>
        <item>
            <title>Serotonin Syndrome After a Massive Overdose of Controlled-Release Paroxetine [CASE REPORTS]</title>
            <link>http://www.medworm.com/index.php?rid=3956375&amp;cid=c_33599_36_f&amp;fid=27163&amp;url=http%3A%2F%2Fpsy.psychiatryonline.org%2Fcgi%2Fcontent%2Fshort%2F51%2F5%2F437%3Frss%3D1</link>
            <description>CONCLUSION: The authors are the first to report on a paroxetine overdose of this magnitude, and they provide one of the few reports on a prolonged course of serotonin syndrome that was unresponsive to standard treatment. (Source: Psychosomatics)</description>
            <author>Psychosomatics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3956375</comments>
            <pubDate>Fri, 10 Sep 2010 18:26:33 +0100</pubDate>
            <guid isPermaLink="false">3956375</guid>        </item>
        <item>
            <title>Neurocognitive effects of brivaracetam, levetiracetam, and lorazepam</title>
            <link>http://www.medworm.com/index.php?rid=4018912&amp;cid=c_33599_25_f&amp;fid=32232&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1528-1167.2010.02746.x</link>
            <description>Summary (Source: Epilepsia)</description>
            <author>Epilepsia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4018912</comments>
            <pubDate>Tue, 31 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4018912</guid>        </item>
        <item>
            <title>Bupropion/lorazepam: CNS disorders, heart disorders and respiratory insufficiency: 2 case reports</title>
            <link>http://www.medworm.com/index.php?rid=3892940&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2010%2F00000001%2F00001315%2Fart00046</link>
            <description>(Source: Reactions)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3892940</comments>
            <pubDate>Tue, 24 Aug 2010 05:51:22 +0100</pubDate>
            <guid isPermaLink="false">3892940</guid>        </item>
        <item>
            <title>Long-term maintenance lorazepam for catatonia: a case report</title>
            <link>http://www.medworm.com/index.php?rid=4591998&amp;cid=c_33599_172_f&amp;fid=35586&amp;url=http%3A%2F%2Fwww.ghpjournal.com%2Farticle%2FPIIS0163834310001350%2Fabstract%3Frss%3Dyes</link>
            <description>We present a case of recurrent catatonia, in which symptoms relapsed whenever an attempt was made to taper off lorazepam. (Source: General Hospital Psychiatry)</description>
            <author>General Hospital Psychiatry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4591998</comments>
            <pubDate>Wed, 11 Aug 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4591998</guid>        </item>
        <item>
            <title>ATIVAN (Lorazepam) Tablet [BTA Pharmaceuticals Inc.]</title>
            <link>http://www.medworm.com/index.php?rid=3818273&amp;cid=c_33599_13_f&amp;fid=35648&amp;url=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fid%3D22026</link>
            <description>Updated Date: Aug 4, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</description>
            <author>DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3818273</comments>
            <pubDate>Wed, 04 Aug 2010 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">3818273</guid>        </item>
        <item>
            <title>What is the Epidemiology and Genetics of the Major Phacomatoses?</title>
            <link>http://www.medworm.com/index.php?rid=3808236&amp;cid=c_33599_33_f&amp;fid=34956&amp;url=http%3A%2F%2Fwww.pediatriceducation.org%2F2010%2F08%2F02%2Fwhat-is-the-epidemiology-and-genetics-of-the-major-phacomatoses%2F</link>
            <description>Discussion
Neurocutaneous syndromes or phacomatoses are a group of congenital or hereditary diseases that develop hamartomas of various tissues and usually additional cutaneous stigmata. Most phacomatoses have quite variable phenotypical presentations for an affected individual. Those that are listed below are common for that disease process.
Learning Point
Common major phacomatosis include:

Sturge-Weber Syndrome

Genetics: non-genetic
Neurological: seizures (often contralateral to the nevus and focal), hemiparesis (again often contralateral to the nevus), mental retardation, ophthalmological problems including glaucoma
Dermatological: port-wine nevus often in the trigeminal nerve&amp;#8217;s first division, hemangiomas
Other clinical features: may be associated with Klippel-Trenaunay-Weber s...</description>
            <author>PediatricEducation.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3808236</comments>
            <pubDate>Mon, 02 Aug 2010 00:00:16 +0100</pubDate>
            <guid isPermaLink="false">3808236</guid>        </item>
        <item>
            <title>High‐dose lorazepam for convulsive status epilepticus in an infant with holoprosencephaly</title>
            <link>http://www.medworm.com/index.php?rid=3874711&amp;cid=c_33599_33_f&amp;fid=32775&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-200X.2010.03077.x</link>
            <description>(Source: Pediatrics International)</description>
            <author>Pediatrics International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3874711</comments>
            <pubDate>Sat, 31 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3874711</guid>        </item>
        <item>
            <title>Prolonged infusions of dexmedetomidine in critically ill patients.</title>
            <link>http://www.medworm.com/index.php?rid=3787229&amp;cid=c_33599_13_f&amp;fid=37389&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20651314%26dopt%3DAbstract</link>
            <description>Conclusion Dexmedetomidine is an alternative to traditional sedatives and analgesics in critically ill patients. The safety and efficacy of dexmedetomidine in adults likely persist beyond 24 hours, without the emergence of rebound effects after discontinuation.
    PMID: 20651314 [PubMed - in process] (Source: American Journal of Health-System Pharmacy : AJHP)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>American Journal of Health-System Pharmacy : AJHP</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3787229</comments>
            <pubDate>Mon, 26 Jul 2010 11:24:39 +0100</pubDate>
            <guid isPermaLink="false">3787229</guid>        </item>
        <item>
            <title>Lorazepam: Osmolar gap metabolic acidosis in an elderly woman associated with propylene glycol excipient: case report</title>
            <link>http://www.medworm.com/index.php?rid=3751827&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2010%2F00000001%2F00001309%2Fart00084</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3751827</comments>
            <pubDate>Thu, 15 Jul 2010 06:25:48 +0100</pubDate>
            <guid isPermaLink="false">3751827</guid>        </item>
        <item>
            <title>Acute Drug Administration in Epilepsy: A Review.</title>
            <link>http://www.medworm.com/index.php?rid=3761782&amp;cid=c_33599_168_f&amp;fid=37274&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20626432%26dopt%3DAbstract</link>
            <description>Conclusions: The best evidence for the efficacy of ADA exists in febrile and nonfebrile childhood seizures, whereas the evidence in catamenial epilepsy is weak. Prevention of clusters is a well-proven principle but its application has been little studied. Prevention of imminent seizures predicted by well-established triggers, defined risk factors, or premonitory minor seizure activity seems to be at the same time the most intelligent and the least investigated application of ADA and would deserve to be better studied.
    PMID: 20626432 [PubMed - as supplied by publisher] (Source: CNS Neuroscience and Therapeutics)</description>
            <author>CNS Neuroscience and Therapeutics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3761782</comments>
            <pubDate>Tue, 06 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3761782</guid>        </item>
        <item>
            <title>Catatonia in a child with autistic disorder.</title>
            <link>http://www.medworm.com/index.php?rid=4143493&amp;cid=c_33599_33_f&amp;fid=36152&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21043395%26dopt%3DAbstract</link>
            <description>We describe herein an 11-year-old pediatric case with autism who developed catatonic symptoms and was treated effectively with lorazepam. The case reported here differs from previously reported cases in terms of age of onset and the display of all characteristics of catatonia as defined in the Diagnostic and Statistical Manual of Mental Disorders (4th ed) (DSM-IV). In addition, although it was stated that catatonia in autism is commonly associated with impaired language and social passivity, our case is an active verbal individual.
    PMID: 21043395 [PubMed - in process] (Source: The Turkish Journal of Pediatrics)</description>
            <author>The Turkish Journal of Pediatrics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4143493</comments>
            <pubDate>Thu, 01 Jul 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4143493</guid>        </item>
        <item>
            <title>Treatment of neonatal withdrawal with clonidine after long-term, high-dose maternal use of tramadol.</title>
            <link>http://www.medworm.com/index.php?rid=3722487&amp;cid=c_33599_13_f&amp;fid=37308&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20587741%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Withdrawal can be prolonged in infants exposed to maternal tramadol use. Clonidine may be a safe and effective option for managing symptoms of neonatal tramadol abstinence.
    PMID: 20587741 [PubMed - in process] (Source: The Annals of Pharmacotherapy)</description>
            <author>The Annals of Pharmacotherapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3722487</comments>
            <pubDate>Wed, 30 Jun 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3722487</guid>        </item>
        <item>
            <title>Brief report: Electroconvulsive therapy for malignant catatonia in an autistic adolescent</title>
            <link>http://www.medworm.com/index.php?rid=3712203&amp;cid=c_33599_25_f&amp;fid=32199&amp;url=http%3A%2F%2Faut.sagepub.com%2Fcgi%2Fcontent%2Fabstract%2F14%2F4%2F349%3Frss%3D1</link>
            <description>A 14-year-old male with autism and mild mental retardation developed malignant catatonia characterized by classic symptoms of catatonia, bradycardia and hypothermia. Bilateral electroconvulsive therapy and lorazepam were required for resolution. The case expands the occurrence of catatonia in autism into its malignant variant. (Source: Autism)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Autism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3712203</comments>
            <pubDate>Wed, 30 Jun 2010 10:13:37 +0100</pubDate>
            <guid isPermaLink="false">3712203</guid>        </item>
        <item>
            <title>Neuroleptic Malignant Syndrome: Further Lessons From a Case Report [CASE REPORTS]</title>
            <link>http://www.medworm.com/index.php?rid=3708895&amp;cid=c_33599_36_f&amp;fid=27163&amp;url=http%3A%2F%2Fpsy.psychiatryonline.org%2Fcgi%2Fcontent%2Fshort%2F51%2F4%2F349%3Frss%3D1</link>
            <description>CONCLUSION: This case sheds further light on the relationship between catatonia and NMS. As noted in the literature, ECT in combination with lorazepam proved to be safe and effective for NMS. (Source: Psychosomatics)</description>
            <author>Psychosomatics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3708895</comments>
            <pubDate>Tue, 29 Jun 2010 18:24:52 +0100</pubDate>
            <guid isPermaLink="false">3708895</guid>        </item>
        <item>
            <title>Lorazepam: Floppy baby syndrome and masking of Klebsiella infection following in utero exposure; neonatal abstinence syndrome following withdrawal: case report</title>
            <link>http://www.medworm.com/index.php?rid=3704190&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2010%2F00000001%2F00001307%2Fart00099</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3704190</comments>
            <pubDate>Tue, 29 Jun 2010 05:33:09 +0100</pubDate>
            <guid isPermaLink="false">3704190</guid>        </item>
        <item>
            <title>Determination of tricyclic antidepressants in human breast milk by capillary electrophoresis.</title>
            <link>http://www.medworm.com/index.php?rid=3672685&amp;cid=c_33599_59_f&amp;fid=36892&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20543503%26dopt%3DAbstract</link>
            <description>Authors: Acedo-Valenzuela MI, Mora-DÃ­ez N, Galeano-DÃ­az T, Silva-RodrÃ­guez A
    A method for the determination of several tricyclic antidepressants (imipramine, desipramine, amitriptyline, nortriptyline, clomipramine, norclomipramine, doxepine and nordoxepine) in breast milk has been developed. This assay consists of a common extraction process in an organic phase, which is evaporated until dried and finally reconstituted in the appropriate buffer for injection in a capillary electrophoresis system. The capillary electrophoresis method used is an &quot;acetonitrile stacking&quot; method previously reported for determining these drugs in serum samples. The method developed was applied to the analysis of these compounds in human breast milk at different concentration levels (50, 100 and 200 ...</description>
            <author>Analytical Sciences : the international journal of the Japan Society for Analytical Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3672685</comments>
            <pubDate>Fri, 18 Jun 2010 17:21:03 +0100</pubDate>
            <guid isPermaLink="false">3672685</guid>        </item>
        <item>
            <title>Non-IV midazolam at least as effective as IV diazepam for status epilepticus - meta-analysis</title>
            <link>http://www.medworm.com/index.php?rid=3668062&amp;cid=c_33599_13_f&amp;fid=38936&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FNews%2F2010---June%2F17%2FNon-IV-midazolam-at-least-as-effective-as-IV-diazepam-for-status-epilepticus---meta-analysis%2F</link>
            <description>Source: Academic Emergency Medicine
Area: News
 Midazolam given by any route is at least as effective as intravenous (IV) diazepam for treatment of status epilepticus (SE) in children and young adults, according to a systematic review and meta-analysis, although the data for adults are limited and require confirmation. 
 &amp;nbsp; 
 Seizures are a common medical emergency: while most will be self-limited, a proportion will progress to SE where seizures are continuous or rapidly recurrent with no interval recovery. If not terminated, SE causes significant morbidity and may be fatal, and the longer it lasts the more resistant to treatment it becomes. Benzodiazepines are the recommended first-line therapy, however the best drug and route of administration is uncertain, especially for use outside...</description>
            <author>NeLM - News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3668062</comments>
            <pubDate>Wed, 16 Jun 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3668062</guid>        </item>
        <item>
            <title>The Unreal World: A series of unfortunate events</title>
            <link>http://www.medworm.com/index.php?rid=3652947&amp;cid=c_33599_26_f&amp;fid=36958&amp;url=http%3A%2F%2Ffeeds.latimes.com%2F%7Er%2Flatimes%2Ffeatures%2Fhealth%2F%7E3%2FifAAYHF7ljU%2Fla-he-unreal-world-20100614%2C0%2C4822069.column</link>
            <description>The 'Royal Pains' season premiere includes some questionable treatment for insomnia, spasms, trauma and mercury exposure.
            
          
          The Premise: &quot;HankMed&quot; physician's assistant Divya Katdare (Reshma Shetty) visits infomercial star Spencer Fisher, a.k.a. &quot;Spencer the Spaz&quot; (Kyle Bornheimer), who is having difficulty sleeping at night. She prescribes a low dose of the sedative Ativan (lorazepam). (Source: L.A. Times - Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>L.A. Times - Health</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3652947</comments>
            <pubDate>Sat, 12 Jun 2010 02:04:25 +0100</pubDate>
            <guid isPermaLink="false">3652947</guid>        </item>
        <item>
            <title>Ictal Epileptic Headache Mimicking Status Migrainosus: EEG and DWI-MRI Findings</title>
            <link>http://www.medworm.com/index.php?rid=3650516&amp;cid=c_33599_25_f&amp;fid=32225&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1526-4610.2010.01709.x</link>
            <description>We report a case of a patient with status migrainosus unresponsive to analgesic therapy in whom electroencephalographic recording revealed an epileptic origin. Intravenous administration of lorazepam induced the prompt resolution of the symptoms. (Source: Headache: The Journal of Head and Face Pain)</description>
            <author>Headache: The Journal of Head and Face Pain</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3650516</comments>
            <pubDate>Wed, 09 Jun 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3650516</guid>        </item>
        <item>
            <title>Ictal Epileptic Headache Mimicking Status Migrainosus: EEG and DWI-MRI Findings.</title>
            <link>http://www.medworm.com/index.php?rid=3686951&amp;cid=c_33599_25_f&amp;fid=32220&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20553328%26dopt%3DAbstract</link>
            <description>We report a case of a patient with status migrainosus unresponsive to analgesic therapy in whom electroencephalographic recording revealed an epileptic origin. Intravenous administration of lorazepam induced the prompt resolution of the symptoms.
    PMID: 20553328 [PubMed - as supplied by publisher] (Source: Headache)</description>
            <author>Headache</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3686951</comments>
            <pubDate>Wed, 09 Jun 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3686951</guid>        </item>
        <item>
            <title>Psychometric evaluation of a visual analog scale for the assessment of anxiety</title>
            <link>http://www.medworm.com/index.php?rid=3643507&amp;cid=c_33599_46_f&amp;fid=34066&amp;url=http%3A%2F%2Fwww.hqlo.com%2Fcontent%2F8%2F1%2F57</link>
            <description>This study evaluates the psychometric properties of a patient-reported Global Anxiety - Visual Analog Scale (GA-VAS).Method: Data from a double-blind, randomized, placebo-controlled study of lorazepam and paroxetine in patients with Generalized Anxiety Disorder were analyzed to assess the reliability, validity, responsiveness, and utility of the GA-VAS. The GA-VAS was completed at clinic visits and at home during the first week of treatment. Targeted psychometric analyses - test-retest reliabilities, validity correlations, responsiveness statistics, and minimum important differences - were conducted.
Results:
: The GA-VAS correlates well with other anxiety measures, at Week 4, r=0.60 (p (Source: Health and Quality of Life Outcomes)</description>
            <author>Health and Quality of Life Outcomes</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3643507</comments>
            <pubDate>Mon, 07 Jun 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3643507</guid>        </item>
        <item>
            <title>Effect of hypnotic drugs on body balance and standing steadiness</title>
            <link>http://www.medworm.com/index.php?rid=3635588&amp;cid=c_33599_146_f&amp;fid=36341&amp;url=http%3A%2F%2Fwww.smrv-journal.com%2Farticle%2FPIIS108707920900118X%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Single dose administration of benzodiazepine hypnotics and Z-drugs significantly impair body balance in a dose-dependent manner. Zolpidem and zopiclone produced similar significant impairment as benzodiazepine hypnotics. Zaleplon significantly impaired balance up to 2 h after intake. Partial tolerance develops after repeated daily use. In conclusion, patients should be warned about the possible risk of imbalance and falls due to the use of sleep medication. (Source: Sleep Medicine Reviews)</description>
            <author>Sleep Medicine Reviews</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3635588</comments>
            <pubDate>Mon, 07 Jun 2010 15:35:24 +0100</pubDate>
            <guid isPermaLink="false">3635588</guid>        </item>
        <item>
            <title>GABAergic control of novelty stress-responsive epigenetic and gene expression mechanisms in the rat dentate gyrus</title>
            <link>http://www.medworm.com/index.php?rid=4585722&amp;cid=c_33599_36_f&amp;fid=35556&amp;url=http%3A%2F%2Fwww.europeanneuropsychopharmacology.com%2Farticle%2FPIIS0924977X10000982%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: The activity of dentate gyrus granule neurons is under a strong GABAergic tonic inhibitory control which contributes to the sparse activation pattern of these neurons after environmental stimuli. Previously, we reported that in sparse dentate gyrus neurons such stimuli evoke Ser-10 (S10) phosphorylation and Lys-14 (K14) acetylation in the nucleosomal protein histone H3 (H3S10p-K14ac) resulting in the induction of c-Fos. We hypothesized that GABA is an important modulator of novelty stress-evoked epigenomic mechanisms in rat dentate neurons. As reported previously, exposure to novelty (30min in new cage) evoked a significant increase in H3S10p-K14ac-and c-Fos-positive neuron numbers in the dentate gyrus. Pre-treatment of rats with the benzo Lorazepam, an indirect GABA-A receptor a...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>European Neuropsychopharmacology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4585722</comments>
            <pubDate>Mon, 07 Jun 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4585722</guid>        </item>
        <item>
            <title>Pregabalin similar to lorazepam for alcohol withdrawal symptoms</title>
            <link>http://www.medworm.com/index.php?rid=3628416&amp;cid=c_33599_49_f&amp;fid=28855&amp;url=http%3A%2F%2Febm.bmj.com%2Fcgi%2Fcontent%2Fshort%2F15%2F3%2F73%3Frss%3D1</link>
            <description>(Source: Evidence-Based Medicine)</description>
            <author>Evidence-Based Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3628416</comments>
            <pubDate>Thu, 03 Jun 2010 15:40:15 +0100</pubDate>
            <guid isPermaLink="false">3628416</guid>        </item>
        <item>
            <title>Midazolam Versus Diazepam for the Treatment of Status Epilepticus in Children and Young Adults: A Meta-analysis.</title>
            <link>http://www.medworm.com/index.php?rid=3752809&amp;cid=c_33599_14_f&amp;fid=28224&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20624136%26dopt%3DAbstract</link>
            <description>Conclusions: Non-IV midazolam, compared to non-IV or IV diazepam, is safe and effective in treating SE. Comparison to lorazepam, evaluation in adults, and prospective confirmation of safety and efficacy is needed. ACADEMIC EMERGENCY MEDICINE 2010; 17:575-582 (c) 2010 by the Society for Academic Emergency Medicine.
    PMID: 20624136 [PubMed - in process] (Source: Accident and Emergency Nursing)</description>
            <author>Accident and Emergency Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3752809</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3752809</guid>        </item>
        <item>
            <title>Lithium/lorazepam/trihexiphenidyl: Neuroleptic malignant syndrome with a reversible splenial lesion: case report</title>
            <link>http://www.medworm.com/index.php?rid=3605165&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2010%2F00000001%2F00001302%2Fart00098</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3605165</comments>
            <pubDate>Fri, 28 May 2010 13:05:51 +0100</pubDate>
            <guid isPermaLink="false">3605165</guid>        </item>
        <item>
            <title>A comparison of statistical approaches used to evaluate change in cognitive function following pharmacologic challenge: an example with lorazepam</title>
            <link>http://www.medworm.com/index.php?rid=3607372&amp;cid=c_33599_172_f&amp;fid=33636&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fhup.1121</link>
            <description>Neuropsychological tests are commonly used in psychopharmacological research to understand the nature and the magnitude of cognitive effects of licensed and novel compounds. While the science of cognitive change assessment has advanced considerably, statistical techniques used to guide inferences about differences in cognitive change have not been considered in the same detail, especially in light of recent advances in modeling repeated data.Data from a randomized, placebo-controlled, crossover study of the effect of an acute dose of lorazepam on cognitive function in healthy adults were analyzed using five statistical approaches (paired sample t-test, area under curve (AUC), repeated measures analysis of variance (ANOVA), change from baseline, and linear mixed models (LMM)). Results of si...</description>
            <author>Human Psychopharmacology: Clinical and Experimental</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3607372</comments>
            <pubDate>Thu, 27 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3607372</guid>        </item>
        <item>
            <title>Despite Known Health Risks Long-Term Use Of Anti-Anxiety Drugs Continues In B.C.</title>
            <link>http://www.medworm.com/index.php?rid=3586774&amp;cid=c_33599_26_f&amp;fid=23292&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2FQYBL0PyzH1o%2F3CW7</link>
            <description>Drugs to treat anxiety and sleep disorders are still being prescribed for extended periods to British Columbian patients - and increasingly so for baby boomers - despite warnings against long-term use, according to a University of British Columbia study. Published online in the journal Health Policy, the study by researchers at UBC's Centre for Health Services and Policy Research (CHSPR) is the first of its kind to examine the use of benzodiazepines such as Xanax and Ativan for an entire population over time... (Source: Health News from Medical News Today)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Health News from Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3586774</comments>
            <pubDate>Sat, 22 May 2010 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">3586774</guid>        </item>
        <item>
            <title>Updated national IV monograph for lorazepam (Ativan®)</title>
            <link>http://www.medworm.com/index.php?rid=3573533&amp;cid=c_33599_172_f&amp;fid=27210&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FNews%2F2010---May%2F18%2FUpdated-national-IV-monograph-for-lorazepam-Ativan%2F</link>
            <description>Source: Medusa
Area: News
 An updated IV monograph for lorazepam (Ativan®) is now available from the NHS injectable medicines guide website (Medusa) at the link below (registration required for access). (Source: NeLM - Mental Health)</description>
            <author>NeLM - Mental Health</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3573533</comments>
            <pubDate>Mon, 17 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3573533</guid>        </item>
        <item>
            <title>Modafinil Overdose</title>
            <link>http://www.medworm.com/index.php?rid=3569390&amp;cid=c_33599_57_f&amp;fid=39029&amp;url=http%3A%2F%2Fwww.thepoisonreview.com%2F2010%2F05%2F16%2Fmodafinil-overdose%2F</link>
            <description>3.5 out of 5 stars
A Retrospective Review of Supratherapeutic Modafinil Exposures. Carstairs SD et al.  J Med Toxicol [published online 01 April 2010]
Abstract
Modafinil (Provigil) is a non-amphetamine stimulant that is sometimes used by college students as an aid to facilitate concentration and studying.  This retrospective review examined all cases of supratherapeutic modafinil exposures reported to the California Poison Control System in the years 1998 &amp;#8211; 2008.  Cases were included if there were no co-ingestants and the outcome was known.
Eighty-seven patients were identified. Doses ranged from 25 mg to 16,100 mg.  The most common clinical effects included tachycardia (26%), agitation (16%), and anxiety (13%).  There were no cases of major clinical effects, cardiac dysrhythmia...</description>
            <author>The Poison Review</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3569390</comments>
            <pubDate>Sun, 16 May 2010 23:12:07 +0100</pubDate>
            <guid isPermaLink="false">3569390</guid>        </item>
        <item>
            <title>Post-traumatic stress disorder in intensive care unit patients</title>
            <link>http://www.medworm.com/index.php?rid=3567781&amp;cid=c_33599_53_f&amp;fid=37455&amp;url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS0103-507X2010000100013%26lng%3Den%26nrm%3Diso%26tlng%3Den</link>
            <description>O transtorno de estresse pós-traumático tem sido descrito em pacientes após tratamento em unidade de terapia intensiva. O objetivo foi revisar estudos sobre os aspectos psicológicos e as intervenções terapêuticas destes pacientes após internação em unidade de terapia intensiva. Trinta e oito artigos foram incluídos. A prevalência de transtorno de estresse pós-traumático variou de 17% a 30% e a incidência de 14% a 24%. Os fatores de risco foram: história prévia de ansiedade, depressão ou pânico, ter memórias traumáticas ilusórias (memórias derivadas de formações psíquicas como sonho e delirium), tempo de ventilação mecânica, experiências estressantes, crenças e comportamentos de característica depressiva. Doses altas de opióides, sintomas na retirada da seda...</description>
            <author>Revista Brasileira de Terapia Intensiva</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3567781</comments>
            <pubDate>Sun, 16 May 2010 14:33:49 +0100</pubDate>
            <guid isPermaLink="false">3567781</guid>        </item>
        <item>
            <title>Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge</title>
            <link>http://www.medworm.com/index.php?rid=3537962&amp;cid=c_33599_172_f&amp;fid=27156&amp;url=http%3A%2F%2Fjop.sagepub.com%2Fcgi%2Fcontent%2Fabstract%2F24%2F5%2F701%3Frss%3D1</link>
            <description>The objective of this study was to use functional magnetic resonance imaging (fMRI) to test the hypothesis that a single dose of lorazepam modifies brain activation during an anxiety challenge. Eighteen healthy male subjects underwent fMRI associated with a challenge based on the anticipation of aversive electrical stimulations after pretreatment, either with placebo or with 1.0 mg of oral lorazepam. Anxiety was rated before fMRI and after, referring to the threat condition periods, using State Trait Anxiety Inventory (STAI) and Hamilton scales. The conditioning procedure induced anxiety, as indicated by clinical rating score changes. Lorazepam did not modify anxiety rating as compared to placebo. Lorazepam reduced cerebral activity in superior frontal gyrus, anterior insula/inferior front...</description>
            <author>Journal of Psychopharmacology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3537962</comments>
            <pubDate>Wed, 05 May 2010 15:46:50 +0100</pubDate>
            <guid isPermaLink="false">3537962</guid>        </item>
        <item>
            <title>Table of Contents</title>
            <link>http://www.medworm.com/index.php?rid=3533717&amp;cid=c_33599_172_f&amp;fid=33592&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fpu.20117</link>
            <description>Combination Therapy at Treatment Initiation Shows Superiority for MDDPhenelzine Plus Group Therapy More Effective Than Monotherapy for SADSt. John's Wort May Cause Increase in Metabolism of OxycodoneAntidepressant Drug Effects and Depression SeverityHow Many Antidepressants Does It Take to Treat Depression?Comparing Lorazepam with Nonbenzodiazepines for AWSAngiotensin Receptor Blockers Reduce Risk of DementiaAripiprazole Use During Pregnancy and Lactation ExaminedApprovals: Silenor for Insomnia (Source: The Brown University Psychopharmacology Update)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>The Brown University Psychopharmacology Update</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3533717</comments>
            <pubDate>Wed, 05 May 2010 15:35:30 +0100</pubDate>
            <guid isPermaLink="false">3533717</guid>        </item>
        <item>
            <title>Lorazepam overdose: Lactic acidosis due to propylene glycol diluent: case report</title>
            <link>http://www.medworm.com/index.php?rid=3525073&amp;cid=c_33599_13_f&amp;fid=33942&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Frea%2F2010%2F00000001%2F00001299%2Fart00074</link>
            <description>(Source: Reactions)</description>
            <author>Reactions</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3525073</comments>
            <pubDate>Mon, 03 May 2010 13:11:00 +0100</pubDate>
            <guid isPermaLink="false">3525073</guid>        </item>
        <item>
            <title>Hunting down a double gap metabolic acidosis</title>
            <link>http://www.medworm.com/index.php?rid=3522244&amp;cid=c_33599_60_f&amp;fid=37240&amp;url=http%3A%2F%2Facb.rsmjournals.com%2Fcgi%2Fcontent%2Fshort%2F47%2F3%2F267%3Frss%3D1</link>
            <description>We describe a 67-year-old woman with acute respiratory failure on mechanical ventilator from pneumonia and anuric acute on chronic renal failure (urea nitrogen 21.4 mmol/L, creatinine 530.4 &amp;micro;mol/L) requiring haemodialysis (HD). On hospital day 5, she was found to have progressive metabolic acidosis (serum pH 7.16, PCO2 4.38 kPa, HCO3&amp;ndash; 12.1 mmol/L and AG 21 mmol/L). There was no evidence of hypoxaemia, hypoperfusion or haemodynamic instability. Normal serum ketone and l-lactate but high serum osmolal gap (89.4 mmol/kg) was detected. A search for toxic alcohols revealed a high serum propylene glycol (PG 32.9 mmol/L), a stabilizing solvent for intravenous formulations of lorazepam, which was being used as sedation for mechanical ventilation. Unexpectedly, serum l- and d-lactate as...</description>
            <author>Annals of Clinical Biochemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3522244</comments>
            <pubDate>Fri, 30 Apr 2010 23:16:24 +0100</pubDate>
            <guid isPermaLink="false">3522244</guid>        </item>
        <item>
            <title>Mephedrone (meow-meow): first confirmed case report</title>
            <link>http://www.medworm.com/index.php?rid=3447819&amp;cid=c_33599_57_f&amp;fid=39029&amp;url=http%3A%2F%2Fwww.thepoisonreview.com%2F2010%2F04%2F07%2Fmephedrone-meow-meow-first-confirmed-case-report%2F</link>
            <description>3.5 out of 5 stars
Recreational Use of Mephedrone (4-Methylmethcathinone, 4-MMC) with Associated Sympathomimetic Toxicity.  Wood DM et al.  J Med Toxicol (published online 01 April 2010).
Abstract
Back in January TPR reported on the alarming reports that were appearing in the British dailies about meow meow (mephedrone), a new synthetic drug that was a derivative of khat (cathinone).  Articles tabloids such as the Sun &amp;#8211; but also in more mainstream papers such as the Times &amp;#8212; reported many deaths associated with mephedrone, as well as reactions so severe that, according to an unconfirmed  web post that may have been a hoax, one agitated user ripped off his own scrotum.  At that time we noted that there were no medical papers in English describing the clinical effects of mep...</description>
            <author>The Poison Review</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3447819</comments>
            <pubDate>Thu, 08 Apr 2010 04:30:28 +0100</pubDate>
            <guid isPermaLink="false">3447819</guid>        </item>
        <item>
            <title>Clinical Effects and Toxicokinetic Evaluation Following Massive Topiramate Ingestion.</title>
            <link>http://www.medworm.com/index.php?rid=3455326&amp;cid=c_33599_57_f&amp;fid=37095&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20376593%26dopt%3DAbstract</link>
            <description>Authors: Lynch MJ, Pizon AF, Siam MG, Krasowski MD
    Topiramate is used to treat a variety of neurologic and psychiatric diseases due to its benign safety profile. Data regarding the toxicity and toxicokinetics of topiramate in acute overdose are limited. A case of massive, acute ingestion resulting in the highest reported topiramate level is presented, including toxicokinetic evaluation. A 37-year-old woman presented with coma unresponsive to naloxone following topiramate ingestion. She had normal vital signs without respiratory depression. She was intubated for airway protection, given 3.5 mg lorazepam IV for facial and neck muscle twitching, and transferred to our facility. No additional sedation was required for 18 h on the ventilator. Following mental status improvement, the patient...</description>
            <author>Journal of Medical Toxicology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3455326</comments>
            <pubDate>Wed, 07 Apr 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3455326</guid>        </item>
    </channel>
</rss>

